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SUMMARY 
A high frequency of pregnancy complications including perinatal mortality and 
congenital malformations such as neural tube anomalies has been shown in 
women with diabetes mellitus. However, the underlying mechanisms contributing 
to these malformations are not clear. The aim of this study was to investigate the 
molecular and morphological changes in cranial neural tubes of embryos from 
diabetic mice. 
Morphological analysis revealed malformations in cranial neural tubes, 
particularly in the telencephalon, diencephalon, and rhombencephalon as well as 
the ventricular system of E11.5 embryos from diabetic mice. The neuroepithelia of 
the forebrain and hindbrain and ventricles appeared to be distorted and fused. The 
molecular changes were analyzed by oligonucleotide microarray which is a useful 
tool to evaluate the expression patterns of thousands of genes involved in 
morphogenesis, cellular functions as well as biochemical and metabolic pathways 
in cranial neural tubes of embryos from diabetic mice. Overall, 1613 genes have 
been found to be differentially expressed in cranial neural tubes of embryos from 
diabetic mice. Among these genes, a total of 390 genes exhibiting greater than 
2-fold changes has been placed into 8 main functional categories as follows: 1. 
metabolism (27.7%); 2. cellular physiological process (20.3%); 3. cell 
communication (12.1%); 4. morphogenesis (6.9%); 5. response to stimulus (3.8%); 
6. cell death (2.3%); 7. cell differentiation (2.1%); 8. small subsets of genes 
(5.4%). 
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SUMMARY               
Further, the microarray analysis shows that several genes involving cell cycle 
progression, migration and differentiation of neuronal and glial cells in cranial 
neural tubes were differentially expressed in embryos of diabetic pregnancy. A 
majority of those genes including doublecortin (Dcx), doublecortin-like kinase 
(Dclk), brain lipid binding protein (Blbp), insulin-like growth factor-2 (Igf-2), 
paired box gene 6 (Pax6), and Neurogenin 2 (Ngn 2) were downregulated in 
embryos of diabetic pregnancy. In addition, maternal diabetes altered the cell 
cycle progression in cranial neural tubes by regulating the expression of genes 
involved in apoptosis and cell proliferation. These results indicate the disruption 
of neuronal migration, neurogenesis as well as axonal wiring, which may 
subsequently result in malformations in developing brains of embryos from 
diabetic mice. 
The neural tube malformation appears to be the result of multiple causes 
including metabolic abnormalities caused by maternal diabetes. Genes involved in 
pathways related to glucose metabolism and hypoxia have been found to be 
altered in cranial neural tubes of embryos from diabetic pregnancy. Maternal 
diabetes has been shown to induce excessive physiological hypoxia and oxidative 
stress, contributing to severe pathological conditions in embryos. In the present 
study, the maternal diabetes-induced physiological hypoxia appeared to have 
triggered an adaptive response in the cranial neural tube by activating the 
expression of several genes encoding enzymes involved in aerobic and anaerobic 
glycolysis pathways. However the adaptive response seems to be insufficient to 
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SUMMARY               
reverse the hypoxic state of the neural tissue in embryos from diabetic mice as 
there was an upregulation of hypoxia-inducible factor-1α (Hif-1α) which is 
activated under hypoxia and rapidly degraded in the presence of oxygen. The 
upregulation of Hif-1α expression is harmful to the development of cranial neural 
tubes in embryos of diabetic pregnancy as it has been shown to promote apoptosis 
and cell growth arrest. Taken together, the altered expression of genes that 
respond to hypoxia appears to be associated with cranial neural tube 
malformations in embryos from diabetic mice.  
In addition, maternal diabetes appears to impair the development of choroid 
plexus (CP) and ventricular system in embryos. CP produces cerebrospinal fluid 
(CSF) which determines the shape of the developing brain and transfers nutrients, 
proteins and other molecules required for neuroepithelial cell survival as well as 
proliferation and neurogenesis during brain development. The CP produces 
several proteins including insulin-like growth factor 2 (Igf-2), which functions as 
a morphogen in inducing differentiation of CP epithelial cells and transthyretin 
(Ttr) which is involved in the transport of thyroxine and retinol, that regulate 
neuronal differentiation in the developing brain. Malformation of the CP and the 
ventricular systems together with reduced production of Ttr and Igf-2 in cranial 
neural tubes of embryos from diabetic mice appear to influence the neuroepithelial 
survival, proliferation and neurogenesis. It is possible that these changes may 
impede further development of functional domains of the brain and subsequently 
contribute to intellectual impairment in the offspring of diabetic mothers. 
xv 
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However, an extensive follow-up study is required to understand the molecular 
mechanisms and consequence of cranial neural tube malformations observed in 
embryos of diabetic mice. 
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1. Diabetes Mellitus 
Diabetes mellitus is a metabolic disorder characterized by high blood glucose 
levels which result from deficiency in secretion or action of insulin. It affects 
various organ systems in the body. The prevalence of diabetes among all age 
groups worldwide in 2000 was estimated to be 2.8%, which was approximately 
171 million people. The total number of diabetics is projected to rise to 366 
million which is 4.4% in the population by 2030 (Wild et al., 2004). In Singapore, 
the incidence of diabetes is increasing while Singaporeans are becoming more 
affluent, their lifestyles are more sedentary and population is ageing rapidly. 
According to the findings from 1998 National Health Survey of Singapore, the 
prevalence of diabetes is approximately 9% among Singaporeans aged from 18 to 
69 years (Tan Bee Yian, Epidemiology and Disease Control Department, Ministry 
of Health Singapore, 1998). 
 
1.1. Definition and classifications of diabetes mellitus 
The term ‘diabetes’ is derived from Greek meaning “pass through” which refers to 
excessive urine production. The word ‘mellitus’ means "honey", a reference to the 
sweet taste of the urine in Latin. Diabetes mellitus (DM) is a metabolic syndrome 
characterized by hyperglycaemia with disturbances of carbohydrate, lipid and 
protein metabolism which is caused by deficiency of insulin secretion, abnormal 
resistance to insulin's action or both (American Diabetes Association, 2007). The 
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chronic hyperglycemia is associated with cardiovascular diseases, chronic renal 
failure, retinal damage, nerve damage, and microvascular damage. 
Diabetes mellitus is classified into three major forms: type 1, type 2, and 
gestational diabetes by The World Health Organization (Alberti and Zimmet, 
1998). Type 1 diabetes occurs due to absolute insulin deficiency caused by 
autoimmune destruction of the pancreatic β-cells. This form of diabetes was 
previously termed as insulin dependent diabetes mellitus (IDDM), or juvenile 
onset diabetes, which accounts for only 5%-10% of those with diabetes. Type 2 
diabetes is characterized by insulin resistance in target tissues.. This form of 
diabetes was formerly termed non-insulin dependent diabetes (NIDDM) or 
adult-onset diabetes mellitus and accounts for 90%-95% of those with diabetes.  
Gestational diabetes (GDM) is defined as a state of glucose intolerance with 
the onset of pregnancy (Carpenter and Coustan, 1982). GDM also involves insulin 
resistance which is similar to type 2 diabetes. The glucose intolerance that occurs 
during pregnancy is often normalized after delivery; however such patients are at 
higher risk of developing diabetes in the future. 
 
1.2. The complications of diabetes mellitus 
Chronic hyperglycemia is a major initiator of vascular complications in diabetics.  
Various hyperglycemia-induced metabolic and hemodynamic abnormalities, 
including increased advanced glycation end product (AGE) formation (Nakamura 
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et al., 1997), enhanced production of reactive oxygen species (ROS) (Du et al., 
2000), activation of protein kinase C (PKC) (Xia et al., 1995), stimulation of the 
polyol pathway (Lee et al., 1995) and the renin-angiotensin system (RAS) (Gurley 
and Coffman, 2007) lead to diabetic vascular complications, such as 
cardiovascular disease (CVD), retinopathy , neuropathy, and nephropathy .  
Diabetes is associated with a marked increase in the risk of CVD. The 
incidence of CVD was 2-4 times higher in diabetic patients than in the general 
population (Stamler et al., 1993). CVD is the predominant reason for death of 
patients with diabetes of over 30 years. In addition, CVD is responsible for about 
70% of all causes of death in patients with type 2 diabetes (Laakso, 1999). 
Moreover, diabetic retinopathy, manifested as microaneurysm and hemorrhage in 
the retina, is a leading cause of acquired blindness among the adult people (Klein, 
2007). The prevalence of diabetic retinopathy increases with duration of diabetes. 
With 30 years of diabetes, almost all patients have some degree of retinopathy and 
the incidence of proliferative retinopathy is about 60%. The prevalence of diabetic 
nephropathy is also markedly increased among individuals with diabetes mellitus. 
Diabetic nephropathy which is a major cause of end-stage renal disease (ESRD), 
develops to glomerular sclerosis accompanied with renal failure (Sharma and 
Ziyadeh, 1995). About 80% of patients with type 1 diabetes for 15 years develops 
diabetic nephropathy. 50% of those with diabetic nephropathy develops ESRD 
over the next 10 years. About 20-40% of type 2 diabetic patients who are treated 
develops overt albuminuria. Among these patients with overt albuminuria, 20% 
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develops ESRD over the following 20 years (Ismail and Cornell, 1999). 
Furthermore, diabetes mellitus causes chronic, widely distributed lesions in the 
peripheral nerves, resulting in diabetic neuropathy which is responsible for 
50-75% of non-traumatic amputations (Caputo et al., 1994). In a large prospective 
study of diabetic patients, the incidence increased from 7.5 % at the time of 
diagnosis of diabetes to 50 % after 25 years with diabetes (Palumbo et al., 1978). 
 
1.3. Maternal diabetes 
Maternal diabetes, which refers to pre-existing diabetes before pregnancy, not 
only affects the general health conditions of pregnant women but also causes 
congenital malformations in fetuses and spontaneous abortions or still birth in 
severe cases (Hawthorne et al., 1997). The relationship between diabetes and 
abnormal pregnancy was described by Bennewitz in the 18th century (Drury, 1961). 
In general, spontaneous abortion and birth defects, such as neural tube defects, 
cardiac anomalies and skeletal abnormalities, appear more frequently in diabetic 
pregnant women than non-diabetic pregnant women. Interestingly, most of the 
affected tissues are formed during the first trimester of pregnancy when 
organogenesis takes place. The defects may be reduced or eliminated if 
euglycemia is achieved during the first trimester of pregnancy (Dicker et al., 1988; 
Mills et al., 1988). In addition, several clinical studies demonstrate that the 
incidence and severity of maternal diabetes-induced defects are correlated with 
poor glycemic control (Goldman et al., 1986; Kitzmiller et al., 1996; Kitzmiller et 
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al., 1991; Steel et al., 1990). 
 
1.3.1. Congenital malformations in embryos of diabetic mother 
Maternal diabetes increases the risk of congenital malformations in fetuses 
resulting in perinatal mortality and neonatal morbidity (Aucott, 1994; Connell et 
al., 1985; Garner, 1995; Hanson, 1993; Ogata, 1995). Studies have shown that 
there is a significant increase in fetal malformations in infants of diabetic mothers 
(Aberg et al., 2001; Day and Insley, 1976; Farrell et al., 2002; Mills et al., 1979; 
Mills, 1982; Ramos-Arroyo et al., 1992; Sharpe et al., 2005). According to 
population based studies in Washington DC and Atlanta, USA, the incidence of 
congenital malformations among infants of diabetic mothers ranges from 7.8% to 
9.7%, while in infants of non-diabetic population, it is approximately 2.1% 
(Becerra et al., 1990; Janssen et al., 1996).  
The maternal diabetes-induced congenital anomalies include both structural 
and functional abnormalities (Gabbe, 1977). The functional malformations include 
macrosomia, cardiomyopathy, and hyperbilirubinemia (Cowett and Schwartz, 
1982), whereas the structural abnormalities include skeletal malformations such as 
sacral agenesis, absence of the femur, ventricular septal defect in the heart, 
pulmonary artery stenosis and gastrointestinal tract abnormalities including 
gastroschisis (Amankwah et al., 1981; Fields et al., 1968). Moreover, a variety of 
central nervous system deformities such as anencephaly, exencephaly, spina bifida, 
and hydrocephalus has also been reported in infants of diabetic mothers (Becerra 
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et al., 1990; Mills et al., 1979). 
 
2. Neural tube development  
The nervous system in vertebrate develops from a simple epithelial sheet, the 
neural plate, from which a variety of neuronal cell types required for the 
construction of a functional nervous system is developed. Brain development 
progresses in an orderly fashion that can be divided into several major stages: the 
neurulation (formation of the neural tube), neuroepithelial cell proliferation and 
migration with formation of transient subplate structures, neuroglial differentiation 
and formation of the neuronal circuits (ten Donkelaar, 2006). 
 
2.1. Neurulation  
Neurulation is a multifactorial process through which the neural tube is formed 
(Smith and Schoenwolf, 1997). In humans, it begins in the 3rd week after 
fertilization by the appearance of the neural groove. Under the inductive influence 
of the notochord, the neuroectoderm cells elongate into columnar cells which form 
the prospective neural plate. The interaction between the neural plate and 
surrounding ectoderm promotes the shaping of neural plate, which lengthens 
along anterior-posterior axis and bends subsequently to form a neural tube (Smith 
and Schoenwolf, 1989). The bending of the neural plate occurs along the midline 
of the neural plate where the cells of the neural plate are called the medial hinge 
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point (MHP) cells. The MHP cells are connected with the notochord beneath them 
and act as a hinge, which forms a furrow at the dorsal midline. Subsequently, two 
other hinge regions form near the connection of the neural plate with the lateral 
ectoderm. The cells of these two regions are called the dorsolateral hinge point 
(DLHP) cells. Each of the three hinges acts as a pivot to direct the rotation of the 
cells around it (Schoenwolf, 1991; Smith and Schoenwolf, 1989, 1991). MHP 
bending creates the ‘neural groove’, with a V-shaped cross section, while DLHP 
bending creates longitudinal furrows that bring the lateral aspects of the neural 
plate towards each other in the dorsal midline. 
The neural folds meet in the midline and undergo fusion, forming the neural 
tube. The first site of the fusion occurs at the junction of the caudal 
rhombencephalon and cranial spinal cord and then proceeds in a zipper like 
fashion cranially and caudally (“continuous closure model”). The open regions of 
the neural tube are called the anterior (cranial) and posterior (caudal) neuropores. 
The cranial neuropore closes approximately at 24 postovulatory days and caudal 
neuropore closes approximately at 26 postovulatory days in the human. The 
secondary neurulation forms the caudal end of the spinal cord below the sacral 
level by epithelialized mesodermal cells (O'Rahilly and Muller, 2002; Sadler, 
2005). It has recently been shown that the neural tube closure occurs at multiple 
sites along the cranio-caudal neuraxis in human embryos (Nakatsu et al., 2000). 
Disturbances during the neurulation lead to malformations resulting in a spectrum 
of neural tube defects.  
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2.1.1. Neural tube defects 
Neural tube closure defects (NTDs), including anencephaly and spina bifida, are 
common human birth defects (Campbell et al., 1986; McBride, 1979). The mouse 
neural tube consists of several cranio-caudal zones (A–D, Illustration 1) within 
which elevation of neural plate passes as a wave longitudinally. The elevated 
neural folds come into apposition, contact and fuse at 6 discrete initiation sites 
within a cranio-caudal zone (Macdonald et al., 1989). From each initiation site 
(closure 1, 2, 3 and 4, Illustration 1), the contact and fusion extends along the 
length of the folds until colliding with fusion initiated from another zone. Failure 
of neural folds to elevate and fuse at the midline causes neural tube closure defects. 
Exencephaly is caused by failure of neural folds to elevate and fuse at the zone B 
or zone B and C of the neural fold (Illustration 1). Failure of elevation of the 
neural folds at other zones causes spina bifida (caudal zone D), craniofacial defect 
of exencephaly with split face (zone A and zone B) and rachischisis (whole of 
zone D). The human NTDs, anencephaly, spina bifida and rachischisis, are 
anatomically similar to mouse NTDs, suggesting that they arise from failure of 
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Illustration 1: Zonal pattern of neural fold elevation and corresponding categories 
of neural tube defects in mouse and human. A–D: elevation zones; 1–4: location 
of initiation sites of neural fold. (Adapted from Juriloff and Harris, 2000)  
 
2.2. Neurogenesis in the developing cranial neural tubes 
During neurodevelopment in mouse, the neural tube forms three vesicles namely, 
prosencephalon, mesencephalon, and rhombencephalon, which give rise to the 
adult forebrain, midbrain and hindbrain, respectively. Before embryonic day 11 
(E11), the three vesicles mainly contain undifferentiated neuroepithelial cells 
acting as precursors for neuronal and glial fates (Morest and Silver, 2003). As the 
cerebral vesicles enlarge, the primitive neuroepithelial cells elongate to become 
radial glial cells which function as the neuronal precursor cells (Levitt et al., 1983) 
and as the migratory substrates for postmitotic neurons (Gasser and Hatten, 1990; 
Hatten and Mason, 1990). The correct specification of radial glial cells is therefore 
essential for normal organization of the developing brain. The neuroepithelial cells 
proliferating in the ventricular zone migrate along the processes of radial glial 
cells through the overlying intermediate zone to marginal zone of pial surface. 
During the process of migration, the neuroepithelial cells differentiate into 
different types of cells which form distinct domains in the brain. Maintenance of 
the ratio of cell proliferation and differentiation is important for proper 
neurodevelopment. It is hypothesized that the impaired proliferation and 
differentiation patterns in the neuroepithelia may contribute to the neural tube 
anomalies. 
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2.2.1 Developmental control genes in the process of neurogenesis 
Several signaling molecules and nuclear transcription factors are part of signaling 
cascades that control proliferation, migration and differentiation of neuronal and 
glial progenitors during neurogenesis. The inductive signaling molecules direct 
cell activity by instructing the synthesis of different transcriptional factors, which 
establish the genetic network necessary for the development of the neural tube. 
However, the mechanisms by which these signaling cascades control the 
neurogenesis are largely unknown.  
In addition, several classes of transcription factors have been shown to 
control the differentiation and specification of precursor cells in the neural tube. 
Recent evidence suggests that combinations of transcription factors of the 
homeodomain proteins such as paired box 6 (Pax6), and basic helix-loop-helix 
(bHLH) proteins such as neurogenin 2 (Ngn2), establish molecular codes that 
determine the fate of neuronal progenitors and glial progenitors by controlling the 
proliferation, specification, and differentiation of neural stem cells (NSCs) during 
development (Ross et al., 2003; Stoykova et al., 2000; Toresson et al., 2000). 
Recently, it has been shown that a number of microtubule-associated proteins 
(MAPs) such as doublecortin (Dcx) are involved in neurogenesis (des, P et al., 
1998) by regulating the key events of mitotic division and migration of neurons 
during neurodevelopment.  
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2.2.1.1. Doublecortin (Dcx) 
Doublecortin (Dcx) is a microtubule associated protein (MAP) which is expressed 
in differentiating and migrating neuronal cells, but is not detected in mature 
neurons under normal conditions (Francis et al., 1999; Gleeson et al., 1999). Dcx 
is expressed primarily in post mitotic neurons during cortical development, 
specifically during periods of neuronal migration as well as neurite formation 
(Francis et al., 1999; Gleeson et al., 1999). Mutations in the human DCX gene are 
associated with abnormal neuronal migration, epilepsy, lissencephaly and mental 
retardation (LoTurco and Bai, 2006). Dclk, a gene that shares high homology with 
Dcx controls the mitotic division and also determines the fate of neural 
progenitors during neurogenesis (Shu et al., 2006).  
 
2.2.1.2. Brain lipid binding protein (Blbp) 
Brain lipid binding protein (Blbp) is a member of the fatty acid-binding protein 
(FABP) family that has been shown to modulate transcription through their 
interactions with nuclear receptors and to play roles in the metabolism 
(Haunerland and Spener, 2004). Blbp is expressed in radial glial cells which 
function as neural progenitors and as a scaffolding supporting neuronal migration. 
Within the cell, Blbp is localized both in the cytoplasm and nucleus in vivo, 
indicating that Blbp is involved in the trafficking of a ligand to a nuclear receptor 
(Feng et al., 1994). In addition, Blbp regulates the migration of developing 
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neurons into cortical layers (Feng et al., 1994). Pathologically, Blbp is 
overexpressed in patients with Downs syndrome, and this overexpression has been 
suggested to contribute to the associated neurological disorders (Sanchez-Font et 
al., 2003).  
Blbp is expressed in radial glia cells of the developing brain and plays a role 
in mediating neuronal-glial signaling. Further it has been shown that Blbp function 
is required for radial glial morphological changes in response to neuronal cues 
(Anton et al., 1997; Feng et al., 1994) and for regulating the morphology and 
axonal interactions of Schwann cells (Miller et al., 2003). Radial glial cells serve 
as the neuronal as well as astrocyte progenitors (Campbell and Gotz, 2002; Gotz 
et al., 2002; Merkle et al., 2004). The dual roles played by radial glia as both 
migratory scaffolding and neuronal progenitors have indicated that there may be 
intimate links between the signaling pathways that control radial glial cell 
development, neurogenesis and neuronal migration (Hatten, 1999; Noctor et al., 
2001; Parnavelas, 2000).  
 
2.2.1.3. Paired box gene 6 (Pax 6) 
Pax 6 encodes a transcription factor containing both a paired domain and a 
homeodomain. It is highly conserved across diverse species. In mammals, it is 
expressed in the eye, specific regions of the CNS, the nasal placodes, olfactory 
epithelium and in the pancreas during development (Grindley et al., 1995; 
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St-Onge et al., 1997; Walther and Gruss, 1991). In mice, Pax 6 begins to be 
expressed on embryonic day 8.5 (E8.5) in the developing eyes, nasal structures, 
spinal cord and forebrain, including the telencephalon (Grindley et al., 1997; 
Mastick et al., 1997; Stoykova and Gruss, 1994). Within the telencephalon, Pax 6 
expression is restricted to the ventricular zone where neurogenesis primarily 
occurs and to the subventricular zone in the dorsal telencephalon where 
gliogenesis primarily occurs (Caric et al., 1997; Gotz et al., 1998). Pax 6 
expression persists in both of these regions throughout neurogenesis and 
gliogenesis, indicating that it may play a vital role in these processes. In addition, 
Pax 6 haploinsufficiency (Pax6+/-) in the mouse results in the Small eye (Sey) 
phenotype (Hill et al., 1991). Homozygotes (Pax6-/-) die perinatally with no eyes 
and multiple brain abnormalities. PAX 6 haploinsufficiency also causes eye and 
brain defects in humans (Estivill-Torrus et al., 2001; Sisodiya et al., 2001; Ton et 
al., 1991).  
Recent studies have suggested that the Pax 6 is important for regulation of 
cell proliferation, migration and differentiation at various sites of the CNS. This 
gene is widely expressed in the developing CNS, including the embryonic cerebral 
cortex, and it has been shown to be required for radial glial cell development and 
neuronal migration (Warren et al., 1999). 
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2.2.1.4. Neurogenin 2 (Ngn2) 
The proneural genes that encode basic helix-loop-helix (bHLH) transcription 
factors play a vital role in establishing the fates of neural progenitors (Bertrand et 
al., 2002; Kageyama and Nakanishi, 1997). The main mouse proneural genes are 
Mash1 (Ascl1), neurogenins (Ngn) and Math1 (Atoh1). These genes have dual 
functions: a) promoting the differentiation of individual progenitors, and b) 
selecting the neuronal or glial lineages. In addition, several lines of evidence have 
shown that they are also involved in specifying neuronal subtype identities.  It has 
been reported that Mash1, Ngn1 and Ngn2 are expressed in a complementary 
pattern in the developing telencephalon and spinal cord and specify distinct 
neuronal subtype identities (Parras et al., 2002). 
The expression of Ngn2 in forebrain progenitor cells promotes the generation 
of glutamatergic neurons (Berninger et al., 2007; Parras et al., 2002). In the 
cerebral cortex, Ngn2 is regulated by Pax 6 to maintain the correct molecular 
identity of cortical progenitors (Stoykova et al., 2000; Toresson et al., 2000; Yun et 
al., 2001). In the spinal cord, Ngn2 promotes cell cycle arrest and neuronal 
differentiation of neuroepithelial cells (Mizuguchi et al., 2001; Novitch et al., 
2001; Scardigli et al., 2001). Ngn2 also acts with Olig2, bHLH transcription factor 
to contribute to the specification of motor neuron progenitors in the spinal cord 
(Mizuguchi et al., 2001; Novitch et al., 2001). 
 
 
CHAPTER 1: INTRODUCTION               
16 
2.3. Glucose metabolism and hypoxia in the developing cranial neural tubes 
In glucose metabolism, glucose is oxidized to synthesize ATP (energy) by 
glycolysis pathway during which the glucose is cleaved into pyruvate. Further 
series of reaction occurs by one of two different pathways: anaerobic which 
occurs in the cytoplasm and aerobic which takes place in the mitochondria. In 
anaerobic glycolysis, the pyruvate is reduced to lactate whereas in aerobic 
glycolysis, pyruvate is transported inside mitochondria and oxidised to acetyl 
coenzyme A. Glucose metabolism is characterized by a high rate of lactic acid 
production in rat embryos during early organogenesis on embryonic day 10 
(Shepard et al., 1970). Glucose also appears to be the predominant substrate for 
the developing brain during embryogenesis. Studies in experimental animals and 
humans indicate that glucose utilization of brain initially is low and increases with 
maturation with increasing regional heterogeneity and increasing functional 
activity (Dyve and Gjedde, 1991; Settergren et al., 1980).  
The developing brain requires enormous supplies of energy to support 
neuronal and glial development during pre-and post-natal development. Murine 
and human brains consume over half the energy available to the organism as a 
whole during this critical period (Gibbons, 1998), when undernutrition may result 
in permanent intellectual deficit (Chase and Martin, 1970). However, the energy 
resources for the developing brain are not known. Insulin enhances energy and 
substrate utilization by peripheral tissues, but does not seem to be involved in the 
regulation of brain metabolism as very little insulin is synthesized in the brain 
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(Baskin et al., 1987). Recently, it has been shown that endogenous brain 
insulin-like growth factor 1 (Igf-1) serves an anabolic, insulin-like role in 
developing brain metabolism (Cheng et al., 2000). 
Maintenance of normal energy metabolism is critical for organogenesis in 
mammalian embryos (Freinkel et al., 1983). It has been shown that glucose uptake 
is increased in embryonic cells without downregulation of glucose transporter, 
Glut1 protein in the diabetic environment and the increased glucose uptake 
induces metabolic overload in the embryonic mitochondria (Yang et al., 1995). 
Further, maternal diabetes-induced glucose uptake into the fetal brain cells has 
been suggested to result in many congenital malformations in embryos (Reece et 
al., 1996). 
 
2.3.1. Glycolysis pathway 
Glycolysis is the metabolic process that converts glucose into pyruvate in the 
cytosol of the cell. The sequence of reactions in the glycolysis pathway is 
catalyzed by ten enzymes which include: Hexokinase (HK), Glucose Phosphate 
Isomerase (GPI), Phosphofructokinase (PFK), Aldolase (ALD), Triosephosphate 
Isomerase (TPI), Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH), 
Phosphoglycerate Kinase (PGK), Phosphoglycerate Mutase (PGM), Enolase 
(ENO), Pyruvate Kinase (PK). The activity of the pathway is regulated at key 
steps to ensure that glucose consumption and energy production match the needs 
of the cell. In mammals, HK, PFK & PK catalyze the key steps which determine 
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the rate of the energy production in the glycolysis pathway (Masters et al., 1987). 
Under anaerobic conditions, pyruvate is converted to lactate by the enzyme 
lactate dehydrogenase (LDH). In the brain, lactate which is a significant energy 
source for neurons is released from astrocytes, which surround and protect 
neurons (Pellerin, 2005). The lactate is taken up by adjacent neurons and 
converted to pyruvate, which is oxidized via Krebs cycle (Bouzier-Sore et al., 
2003; Itoh et al., 2003). Impaired energy production may lead to lethal 
consequences in cells and hence manipulation of metabolism may provide a 
therapeutic strategy.   
 
2.3.2. Hypoxia in the developing cranial neural tubes 
Hypoxia is a well-known teratogen contributing to congenital malformations in 
mouse embryos (Curley and Ingalls, 1957). Physiological hypoxia, caused by the 
increasing mass of the avascular early postimplantation embryo, plays a critical role 
during normal embryogenesis. The embryo is relatively in a state of partial 
hypoxia which is essential for proper morphological development (Chen et al., 
1999). This physiological hypoxia activates the hypoxia-inducible factor 1-α 
(Hif-1α), a heterodimeric transcription factor to induce expression of genes that in 
turn trigger hematopoiesis and development of structures forming the circulatory 
system, thereby increasing O2 delivery to embryonic tissues and reducing the 
hypoxic state (Adelman et al., 1999; Iyer et al., 1998). Increased O2 delivery may be 
critical for the development of organ systems including nervous system. Thus 
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failure to increase O2 delivery at this stage of development may impair activation of 
genes needed for formation of the various organs including the neural tube. It has 
been shown that excessive hypoxia in embryos causes abnormal development of 
the brain (Giusti et al., 2008), heart (Tintu et al., 2007) and cleft lip (Paulozzi and 
Lary, 1999). In human beings, hypoxia has been shown to cause intrauterine 
growth retardation, developmental delay, and intrauterine death (Ergaz et al., 
2005). Further, the central nervous system is known to be critically affected in the 
prenatal–perinatal period by hypoxic–ischemic insults, which produce several 
disorders such as loss of neural projections, increased susceptibility to seizures, 
apoptosis and an imbalance in normal activity of glutamatergic and GABAergic 
neurons, resulting in acute cell excitotoxicity (Rodriguez Gil et al., 2000). 
 
2.3.2.1. Hypoxia-inducible factor 1 (Hif-1) 
Hypoxia-inducible factor 1 (Hif-1) is the master regulator of cellular responses to 
the state of hypoxia (Poellinger and Johnson, 2004; Semenza, 1999). Hif-1 is a 
heterodimeric basic helix–loop–helix–PAS domain (bHLH-PAS) transcription 
factor, composed of Hif-1α and Hif-1β subunits (Wang et al., 1995). HIF-1β, 
which is the aryl hydrocarbon receptor nuclear translocator (ARNT) (Hoffman et 
al., 1991), is a common subunit of multiple bHLH-PAS proteins. Hif-1α is the 
unique O2-regulated subunit that determines Hif-1 activity (Semenza, 1999). 
Levels of Hif-1α protein and Hif-1 DNA-binding activity are increased 
exponentially when O2 concentration decreased (Jiang et al., 1996).  
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Hif-1 regulates the expression of a wide range of genes, protein products of 
which allow metabolic adaptation to low oxygen conditions. These genes include 
genes encoding erythropoietin (EPO) (Wang and Semenza, 1993), transferrin (Lee 
and Andersen, 2006), inducible nitric oxide synthase (iNOS) (Palmer et al., 1998), 
and vascular endothelial growth factor (Vegf) (Forsythe et al., 1996). In addition, 
Hif-1 activates transcription of genes encoding glycolytic enzymes, such as ALD 
1A, ENO 1, LDHA, PFK and PGK 1 (Wenger and Gassmann, 1997). These 
proteins play important roles in systemic, local or intracellular O2 homeostasis: 
EPO increases blood O2-carrying capacity by stimulating erythropoiesis (Wang 
and Semenza, 1993); transferrin delivers iron to the bone marrow for 
incorporation into hemoglobin (Primosigh and Thomas, 1968); iNOS synthesizes 
NO which modulates vascular tone (Worthington et al., 2000); and induction of 
glycolytic enzymes allows for increased anaerobic ATP synthesis (Scheuer, 1972); 
Vegf mediates vascularization, particularly during embryonic development (Breier 
et al., 1992).  
On the other hand, HIF1 signal regulation could be detrimental instead of 
adaptive in some circumstances. For instance, HIF1 induces expression of BNIP3, 
a proapoptotic member of the BCL2 family, which induces apoptosis (Bruick, 
2000; Sowter et al., 2001). Moreover, HIF1 also induces expression of IGFBP-3 
(Feldser et al., 1999; Liu et al., 1992) and P21 (Goda et al., 2003) which 
negatively regulate cell proliferation and cell cycle. 
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2.3.2.2. Vascular endothelial growth factor (Vegf) 
Since hypoxia induces angiogenesis as a compensatory mechanism to supply 
adequate oxygen, hypoxia is one of the most potent inducers of several 
well-known angiogenic factors including vascular endothelial growth factor (Vegf) 
(Mazure et al., 1996; Plate et al., 1992). Vegf is considered as a key regulator of 
angiogenesis particularly during embryonic development (Breier et al., 1992; 
Dumont et al., 1995; Millauer et al., 1993). Several studies have shown that 
development of the cardiovascular system is exquisitely dependent on normal 
levels and appropriately timed expression of Vegf. Loss of a single Vegf allele is 
lethal in the mouse embryo between days 11 and 12 (Ferrara et al., 1996). 
Conversely, even a modest upregulation of Vegf levels during development leads 
to severe abnormalities in heart development and embryonic lethality (Miquerol et 
al., 2000). 
 
2.4. Choroid plexus development 
2.4.1. Choroid plexus (CP)  
CP is a specialized secretory organ situated within the ventricles of the brain. CP 
is composed of a simple epithelial layer with underlying connective tissue and 
blood vessels. The CP epithelial cells produce cerebrospinal fluid (CSF) which 
fills the ventricular system, enters the subarachnoid space and circulates around 
the brain and spinal cord (Speake et al., 2001). Subsequently, CSF is absorbed into 
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blood vessels through arachnoid villi. The CP and CSF play important roles 
(nutritive, mechanical, metabolic and immune) in brain physiology and 
neurological diseases (Emerich et al., 2005; Engelhardt et al., 2001; Strazielle and 
Ghersi-Egea, 2000). The CSF-borne molecules appear to pass through the CP 
epithelium and regulate the brain functions. CP also serves as an important 
channel for the entry of therapeutic drugs as it is a major component of the 
blood-CSF and blood-brain barriers which segregate CNS environment from the 
circulating blood (Johanson et al., 2005). During brain development, CP has been 
shown to function as a signaling centre (Yamamoto et al., 1996). Recently, it has 
shown that the regulatory factors found in the CSF promote cell survival, 
proliferation, and neurogenesis during brain development (Parada et al., 2005).  
 
2.4.2. Development of CP in mouse embryos 
The CP first begins to appear shortly after the neural tube closure in the cerebral 
ventricles of the developing brain of mouse embryos (Dziegielewska et al., 2001). 
It develops in the order of fourth ventricles at E10-10.5, lateral ventricles at E11 
and third ventricles afterwards in the mouse brain (Sturrock, 1979). The CP 
consists of a single layer of epithelial cells around the mesenchymal (stromal) 
tissue containing blood vessels (Dziegielewska et al., 2001). The epithelial cells of 
the CP express and transfer proteins and other metabolically important molecules 
essential for brain development, such as transthyretin (Ttr) and insulin-like growth 
factor 2 (Igf-2). Furthermore, the CP has been implicated as a secondary signaling 
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center during brain development (Yamamoto et al., 1996). It also provides an 
essential expanding mechanism that determines the shape of the brain during its 
development (Dziegielewska et al., 2001). It is hypothesized that the impairment 
of CP development causes adverse effects on the patterning and shaping of the 
developing brain. 
 
2.4.3. Factors involved in CP development 
2.4.3.1. Transthyretin (Ttr) 
Transthyretin (Ttr) is a 55-KD tetrameric carrier protein which was first detected 
in CSF and serum. It was originally called prealbumin. In the blood, Ttr binds to 
thyroid hormones with high affinity (Blake and Oatley, 1977) and retinol via 
retinol-binding protein (Muto and Goodman, 1972). The function of Ttr is to 
transport thyroid hormones from the blood to brain (Schreiber et al., 1990). 
In the brain, Ttr is expressed in CP epithelial cells and is regarded as a 
marker of CP epithelium (Murakami et al., 1987). Ttr mRNA expression has been 
shown to be localized in the primordial CP epithelium prior to CP morphogenesis 
and in the developing CP of the fourth and lateral ventricles of the rat embryos at 
E13 (Cavallaro et al., 1993; Makover et al., 1989). In addition, Ttr protein is first 
detected in the tela choroidea which is the developmental forerunner of the CP. Ttr 
protein continues to express in the CP of fetal rat at the E14 days as well as at the 
E18 days (Kato et al., 1986). The level of Ttr mRNA expression in CP is increased 
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during the first half of gestation and stayed constant thereafter until birth (Tu et al., 
1990). Ttr plays an important role in vitamin A and thyroid hormone metabolism 
in the developing embryo (Makover et al., 1989). Particularly, it serves to 
transport thyroxine (T4) or retinol (metabolite of vitamin A) across the 
blood-retina barrier, thereby facilitating their effects on cell differentiation and 
brain morphogenesis. 
 
2.4.3.2. Insulin-like growth factor 2 (Igf-2) 
Insulin-like growth factor 2 (Igf-2) is a polypeptide hormone with structural and 
functional homology with Igf-1 and pro-insulin. Igf-2 acts as a growth factor 
during fetal development (Baker et al., 1993; Heyner and Garside, 1994). Igf-2 
levels in the circulation are high in the fetus and decline rapidly after birth. 
Targeted disruption of the Igf-2 gene in mice leads to a deficiency in growth and 
differentiation factor in the central nervous system (Kiess et al., 1994).  
Igf-2 mRNA expression is localized in many tissues including the liver and 
CP in the brain. In the rat, Igf-2 mRNA expression begins at E13 and increases 
gradually as morphogenesis proceeds. In the CP stroma (mesenchyme), Igf-2 
mRNA is abundant prior to CP morphogenesis but decreases as embryogenesis 
proceeds and is absent in the adult (Cavallaro et al., 1993), suggesting that Igf-2 
acts as a morphogen in inducing differentiation of CP epithelial cells during brain 
development (Cavallaro et al., 1993) 
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3. Analysis of global gene expression profile using DNA microarray 
Human Genome Project (HGP), which has been launched for more than 15 years, 
has established the blueprint of genome sequences of human and provided a solid 
basis for translational researches from genomics to post-genomics. In the 
post-genomics era, researchers are focusing on the function of each gene in the 
genome on the biological processes. This new area is called functional genomics 
which is the functional analysis of gene expression profile using DNA microarray 
technique (Lander, 1999)  
 
3.1. Overview of DNA microarray technology 
Each array consists of thousands of genes attached to a solid support. Fluorescent 
labeled RNA or DNA is hybridized to complementary DNA on the array and 
detected by a laser scanner. After the hybridization intensities for each DNA on 
the array are determined, the microarray data can be further analyzed to identify 
expression patterns and variation that correlate with biological processes. There 
are two types of DNA microarray. One is the spotted microarray on which the 
pre-synthesized DNA samples are bound, and the other is oligonucleotide 
microarray. In oligonucleotide microarray, the DNA fragments synthesized are 
spotted on glass surface using the photolithographic method. 
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3.2. Basic principle of DNA microarray 
The basic principles of spotted microarray and oligonucleotide microarray are 
similar. Firstly, total RNA or messenger RNA isolated from samples of either 
control or experimental groups is reversely transcripted to cDNA or converted to 
cRNA by incorporating fluorescent dyes. The labeled cDNA or cRNA is 
hybridized to microarray chips for a period of time, after which the excess cDNA 
or cRNA is washed off and the microarray chips are scanned under a laser scanner 
(Heller, 2002).  
 
Spotted microarray:  
Although the basic principles of these two types of microarray are similar, they 
also have their own characteristics. On spotted arrays, the DNA fragments are 
longer than several hundred base pairs. The cDNA samples of control and test 
groups are labeled with different fluorophores, cy3-dUTP and cy5-dUTP and then 
hybridized onto the array. Relative amount of a particular gene transcript in the 
two samples is determined by measuring the signal intensities detected by the two 
fluorophores and calculating signal ratios (Ferea and Brown, 1999). 
 
Oligonucleotide array:  
On oligonucleotide microarray, each gene is presented by 15-20 different 
oligonucleotides with 25 base pairs. For cross hybridization control, each gene has 
a mismatch (MM) probe set which is identical to the perfect match transcript 
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except for one base pair in the middle. Based on the signal of mismatched 
oligonucleotide, cross-hybridization and local background is estimated and 
subtracted from the perfect match signal (PM). In the oligonucleotide array, 
biotinylated cRNA is transcribed from mRNA of control and test samples and the 
cRNA of each sample is hybridized to a separate array. Differences in mRNA 
levels between samples are determined by comparison of hybridization patterns 
produced on separate arrays. (Lipshutz et al., 1995; Lockhart et al., 1996; Pease et 
al., 1994) 
 
Differences between the 2 arrays and advantage of oligonucleotide array: 
There are two main differences between spotted microarray and oligonucleotide 
microarray: 1) For spotted microarrays, each probe has its own hybridization 
character, since the DNA fragments are synthesized individually and the length of 
them is also different. However, for the oligonucleotide microarray, all probes are 
designed to have similar hybridization temperature and binding affinity, which 
allow minimization of the hybridization differences among the target genes. 2) 
The spotted microarray measures two samples together and provides relative 
amount of each target gene between two samples. The oligonucleotide array 
measures each sample separately and gives the absolute amount of target gene in 
each sample, which allows flexibility in sample comparisons. Since 
oligonucleotide array has similar probe hybridization character and may be used 
in research with more than two samples. In the present study, oligonucleotide 
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microarray was used. 
 
3.3. Applications of DNA microarray 
DNA microarray can be applied in many aspects of basic and clinical research. In 
basic research, DNA microarray is normally applied to identify novel genes (Certa 
et al., 2001), determine gene function (Certa et al., 2002), generate expression 
profile (Lukiw, 2004) and elucidate signaling pathways (Carrasquillo et al., 2002). 
DNA microarray can also be used in a wide variety of clinical research, such as 
drug target discovery (Gerritsen et al., 2002), biomarker determination (Flach et 
al., 2006), prognostic tests development (De et al., 2006), and disease-subclass 
determination (Koehler et al., 2004). 
 
3.4. Data analysis strategies 
There are three steps for data analysis: data normalization, data filtering and 
pattern identification. Initially data are normalized before comparing expression 
values. Following this, uninformative genes are filtered out from the data. The 
final step is to find patterns and groups of genes that have similar biological 
meaning. The methods for the final steps are basically two types: One is to list the 
increased and decreased genes based on threshold, and the other is sophisticated 
clustering (Claverie, 1999) which uses a progressive combination of elements that 
are the most similar. 
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4. Animal models 
4.1. Animal models of diabetes mellitus 
Animal model is a useful tool for researchers to investigate the disease states in 
ways which may not be accessible in human patients. Rodents, such as rats and 
mice, are most commonly used as diabetic animal models since they are small in 
size, manageable and cost effective. The rodent animal models of diabetes display 
the similar symptoms of human disease although rodents may not adequately 
reflect the human situation. 
According to their clinical similarity to human disease, the animal models of 
diabetes can be classified into two types: animal models of insulin-dependent 
diabetes (IDDM) and non-insulin dependent diabetes (NIDDM). The animal 
models of IDDM can be induced by viral infection (Craighead, 1981), chemical 
destruction of pancreatic β-cells (Like and Rossini, 1976), partial pancreatectomy 
(Freyse et al., 1982; Reiser et al., 1987), or immunologic mechanisms which 
inactivate insulin or destroy pancreatic islets (Toreson et al., 1968), resulting in 
destruction of islet β-cells that lead to an absence of intrinsic insulin secretion.  
Type 1 diabetes mellitus in humans is characterized by a specific destruction 
of the β cells in the pancreas. Therefore, toxin-mediated damage to the 
insulin-producing pancreatic β-cells  is a useful tool in the study of the 
consequences of hyperglycaemia, such as diabetic complications (Flyvbjerg et al., 
1995; Reagan et al., 1999; Yu et al., 2001). Streptozotocin (STZ) is one of the 
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most commonly used chemicals producing hyperglycaemia by selective 
destruction of β cells in pancreatic islets (Junod et al., 1969). 
 
4.1.1. Mechanism of action of streptozotocin (STZ)  
Streptozotocin (STZ) is an N-nitroso derivative of D-glucosamine isolated from 
Streptomyces achromogenes. STZ has broad-spectrum antibiotic and 
anti-neoplastic activity (Bono, 1976) and it has been shown to disturb glucose 
transport (Wang and Gleichmann, 1998), glucokinase function (Zahner and 
Malaisse, 1990) and induce multiple DNA strand breaks in rat pancreatic β cells 
(LeDoux et al., 1986). Subsequently, this chemical acts as diabetogen as it 
selectively destroys pancreatic β cells in several species (Junod et al., 1967; 
Rakieten et al., 1963). A single large dose of STZ (200-250 mg/kg body weight) or 
multiple low doses of STZ (40 mg/kg body weight) on five consecutive days can 
induce diabetes in rodents by producing progressive loss of β cells and 
hyperglecaemia associated with intense pancreatic insulitis (Junod et al., 1967; 
Like et al., 1978).  
 
4.2. Animal model of maternal diabetes 
The diabetic animal models induced by STZ have been widely used for the study 
of teratogenic effects of maternal diabetes on fetal development and possible 
mechanisms of maternal diabetes-induced congenital malformations (Cederberg et 
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al., 2003; Giavini et al., 1986; Hiramatsu et al., 2002; Liao et al., 2004; Sakamaki 
et al., 1999; Wentzel et al., 2005). Initially, alloxan, another diabetogenic agent 
injected into pregnant mice between gestational day 8.5 and13.5 caused a high 
maternal death rate (Watanabe and Ingalls, 1963), together with a wide range of 
congenital malformations, high embryo death rate and delayed development 
(Baker et al., 1981; Deuchar, 1977; Eriksson et al., 1983).  Subsequently it has 
been demonstrated that STZ induced diabetes is severe and showed low fertility 
and high preimplantation losses, low fetal weight and high placental weight 
(Giavini et al., 1986). The reliability of this animal model was further confirmed 
by comparing the results of in vivo experiments with the results of clinical practice 
in the following aspects: 
1. The frequency of congenital malformation in the offspring of diabetic rats 
or mice is around 6 to 8 times higher than the normal rate. Similar rate is 
reported in diabetic women (Becerra et al., 1990; Janssen et al., 1996).  
2. The most frequent malformations observed are: defects in cardiovascular 
and central nervous systems and caudal regressions in the offspring of 
both animal models and diabetic women (Aberg et al., 2001; Eriksson, 
1984). 
3. The increased frequency of embryo resorption in diabetic rats mimics the 
high rate of abortions in diabetic women (Greene, 1999; Moley, 2001). 
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5. Hypotheses and Objectives  
It is well established that diabetic women exhibit higher incidences of pregnancy 
complications such as spontaneous abortion, still birth and congenital 
malformations in various organ systems including the central nervous system 
(Becerra et al., 1990; Greene et al., 1989; Hawthorne et al., 1997; Mills et al., 
1979). Several studies have attempted to demonstrate the molecular and 
biochemical mechanisms of maternal diabetes-induced congenital malformations 
in rodents. Recently, it has been shown that altered expression pattern of some 
genes involved in regulating the forebrain patterning and neural tube closure, 
leads to forebrain patterning defects and NTD in embryos of diabetic pregnancy 
(Liao et al., 2004; Phelan et al., 1997). Further, results obtained from in vitro 
analysis indicated that high glucose impairs the proliferation and cell fate 
specification of NSCs and this impairment may form the basis for neural tube 
anomalies in embryos of diabetic pregnancy (Fu et al., 2006). A number of studies 
described that the development of malformations in various organs (including the 
neural tube) in diabetic pregnancy could be due to metabolic derangements caused 
by a deficiency of polyols, oxidative stress and physiological hypoxia (Baker et al., 
1990; Chang et al., 2003; Goldman et al., 1985; Hashimoto et al., 1990; Hiramatsu 
et al., 2002; Li et al., 2005). These reports did not fully explore the molecular 
mechanisms of neural tube patterning defects as the neural tube development is a 
complex process and is regulated by a number of signaling molecules and 
transcription factors. Global analysis of expression patterns of thousands of genes 
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simultaneously by microarray technology in the cranial neural tube of embryos 
from normal and diabetic mice may unravel the molecular changes which 
contribute to brain anomalies in infants of diabetic pregnancies.  
During development, the neural tube forms three vesicles namely, 
prosencephalon, mesencephalon, and rhombencephalon, which give rise to the 
adult forebrain, midbrain and hindbrain, respectively. Before embryonic day 11 
(E11), the three vesicles mainly contain undifferentiated neuroepithelial cells 
acting as precursors for neuronal and glial fates (Morest and Silver, 2003). As the 
cerebral vesicles enlarge, the primitive neuroepithelial cells elongate to become 
radial glial cells which function as the neuronal precursor cells (Levitt et al., 1983) 
and as the migratory substrates for postmitotic neurons (Gasser and Hatten, 1990; 
Hatten and Mason, 1990). The correct specification of radial glial cells is therefore 
essential for normal organization of the developing brain. The neuroepithelial cells 
proliferating in the ventricular zone migrate along the radial glial cells to marginal 
zone and differentiate into different types of cells which form distinct domains in 
the brain. Maintenance of the ratio of cell proliferation and differentiation is 
important for proper brain patterning. It is hypothesized that the impaired 
proliferation and differentiation patterns in the neuroepithelia contribute to brain 
anomalies in infants of diabetic pregnancies. 
Another component of the brain, i.e., choroid plexus (CP) which is a 
specialized secretory organ situated within the ventricles of the brain also plays an 
important role in early brain development. The CP first begins to appear shortly 
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after the neural tube closure in the ventricles of cranial neural tube of mouse 
embryos (Dziegielewska et al., 2001). It develops in the order of 4th ventricles at 
E10-10.5, lateral ventricles at E11 and 3rd ventricles afterwards in the mouse 
brain (Sturrock, 1979).  The CP consists of a single layer of epithelial cells 
around the mesenchymal tissue containing blood vessels and produces the cerebral 
spinal fluid (CSF) which provides an essential expanding mechanism that 
determines the shape of the brain during its development (Dziegielewska et al., 
2001). The epithelial cells of the CP transfer proteins and other metabolically 
important molecules essential for brain development. Furthermore, the CP has 
been implicated as a secondary signaling center during brain development 
(Yamamoto et al., 1996). It is hypothesized that the impairment of CP 
development causes adverse effects on the patterning and shaping of the 
developing brain. 
The objective of this study was to investigate the molecular and 
morphological changes in the neuroepithelia of the cranial neural tube including 
telencephalon, diencephalaon and, rhombencephalon and choroid plexus in 
embryos from diabetic mice. The molecular changes were analyzed by using 
oligonucleotide microarray which is a useful tool to evaluate the expression levels 
of thousands of genes involved in morphogenesis, cellular functions as well as 
biochemical and metabolic pathways in cranial neural tubes of embryos from 
diabetic mice. 
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5.1. Specific aims 
1. Morphology of cranial neural tubes in embryos of diabetic mice was analyzed 
histologically using Haematoxylin and Eosin (H&E) staining. 
2. Global gene expression profile of the cranial neural tubes in embryos from 
diabetic mice and normal mice was analyzed using Affymetrix oligonucleotide 
microarray. Genes that were found to be differentially expressed between 
control and experiment groups were hierarchically clustered using 
bioinformatics software and the functions of these genes were analyzed based 
on Gene Ontology Consortium database [http://www.geneontology.org/].  
3. The differentially expressed genes selected according to their functions in 
neurogenesis, neuronal migration, glucose metabolism and physiological 
hypoxia were further examined by in situ hybridization, real time RT-PCR, 
immunohistochemistry and western blot. 
4. The proliferation index and apoptosis in the cranial neural tube of embryos 
from diabetic and normal mice were investigated by immunohistochemical 
detection of BrdU incorporation and TUNEL assay, respectively. 
5. Morphology of choroid plexus in the cranial neural tube of embryos from 
diabetic mice was examined histologically using H&E staining and specific 
markers of choroid plexus, such as Ttr and Igf-2, were studied using 
immunohistochemistry. 
 
Analysis of gene expression profiles may help identifying novel key molecules 
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involved in the cranial neural tube malformations of embryos from diabetic mice. 
This may provide better insights into the development of therapeutic options for 
the fetal malformations in diabetic pregnancy and the determination of biomarkers 
to identify the possible fetal abnormalities in utero. 
 
















CHAPTER 2: MATERIALS AND METHODS               
38 
1. Animals 
Swiss albino mice (8-10 weeks) were used for the present study. The mice were 
purchased from the Laboratory Animal Centre (National University of Singapore, 
Singapore) and housed in clean cages (not more than 4 mice in one cage) in a 
temperature-controlled room with 14h light and 10h dark schedule. Altogether, 
271 embryos collected from 64 diabetic mice and 305 embryos from 64 normal 
mice were used for this study (Table 1). All procedures involving animal handling 
were in accordance with the guidelines of the Institutional Animal Care and Use 
Committee (IACUC), National University of Singapore. 
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Table 1: Animals used in this study 
Species Age Sex Number Experiments 
Swiss Albino Mouse 8-10 weeks Female 64 Diabetic pregnancy 
Swiss Albino Mouse 8-10 weeks Female 64 Normal pregnancy 
Swiss Albino Mouse 8-10 weeks Male 35 Used for mating 
3 from DP (n=3) 
E11.5 
3 from NP (n=3) 
3 from DP (n=3) 
Swiss Albino Mouse 
E13.5 
Nil 
3 from NP (n=3) 
Histological analysis 
227 from DP 
Swiss Albino Mouse E11.5 Nil 
261 from NP 
Malformation analysis 
in whole mount embryo
3 from DP (n=3) 
Swiss Albino Mouse E11.5 Nil 
3 from NP (n=3) 
Microarray 
4 from DP (n=4) 
E11.5 
4 from NP (n=4) 
4 from DP (n=4) 
Swiss Albino Mouse 
E13.5 
Nil 
4 from NP (n=4) 
Real time RT-PCR 
3 from DP (n=3) 
E11.5 
3 from NP (n=3) 
6 from DP (n=6) 
Swiss Albino Mouse 
E13.5 
Nil 
6 from NP (n=6) 
Immunohistochemistry 
3 from DP (n=3) 
E11.5 
3 from NP (n=3) 
3 from DP (n=3) 
Swiss Albino Mouse 
E13.5 
Nil 
3 from NP (n=3) 
BrdU labeling analysis 
6 from DP (n=6) 
Swiss Albino Mouse E11.5 Nil 
6 from NP (n=6) 
In situ hybridization 
3 from DP (n=3) 
Swiss Albino Mouse E11.5 Nil 
3 from NP (n=3) 
TUNEL 
3 from DP (n=3) 
Swiss Albino Mouse E11.5 Nil 
3 from NP (n=3) 
Western blot 
E: embryonic day; DP: diabetic pregnancy; NP: normal pregnancy; n: number of pregnant adult 
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2. Induction of diabetes mellitus 
STZ (an N-nitroso derivative of glucosamine) is one of the most commonly used 
diabetogen, inducing insulin-dependent diabetes mellitus in rodents by causing 
selective destruction of insulin-secreting β-cells in pancreatic islets (Junod et al., 
1969; Rossini et al., 1977). These experimental diabetic animal models have been 
widely used to study the diabetes-induced changes in various adult tissues (Dheen 
et al., 1994; Kamal et al., 1991) and to understand the molecular mechanisms of 
maternal diabetes-induced malformations in various organs including the neural 
tube in embryos (Eriksson et al., 2003; Fine et al., 1999; Liao et al., 2004; Phelan 
et al., 1997). 
Materials 
Streptozotocin (STZ)   (Cat. No. S0130, Sigma, USA) 
0.01M sodium citrate buffer: 
Deionised water 100ml 
Sodium citrate  2.94g 
The pH was adjusted to 4.5 by adding 0.01mol/l citric acid. 
Procedure 
The STZ was freshly dissolved in 0.01M sodium citrate buffer at a concentration 
of 24mg/ml. Diabetes mellitus was induced in 8-10 week-old female Swiss albino 
mice with an intraperitoneal injection of STZ (90mg/kg body weight) on three 
successive days under aseptic conditions. 
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2.1. Blood glucose test 
Blood glucose level was measured three days after STZ injection. Mouse was kept 
in a mouse-restrainer and the tip of its tail protruded out of the restrainer was cut 
by a sharp sterile blade. One drop of blood was placed onto a blood glucose strip. 
After 20 sec, blood glucose level was displayed on a LCD monitor of blood 
glucose meter (Medisense Precision Q.I.D. Blood Glucose Meter, UK). Only 
those mice with non-fasting blood glucose level exceeding 300mg/dl were used as 
experimental diabetic mice. Age-matched control mice used in the present study 
showed non-fasting blood glucose level less than 130mg/dl. 
 
2.2. Collection of embryos 
Materials 
0.1M phosphate-buffered saline (0.1M PBS): 
Di-sodium hydrogen phosphate heptahydrate 13.3g 
Sodium chloride            8.5g 
Deionized H2O was added to make up to 1 liter.  
The pH was adjusted to 7.4 with 1N HCl solution. 
5-bromo-2-deoxyuridine (BrdU) solution 
BrdU (Cat. No. B5002, Sigma-Aldrich, USA)  10mg 
Sterile H2O                         1ml 
The BrdU powder was freshly dissolved in sterile H2O at a 
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concentration of 10mg/ml. 
Procedure 
Four diabetic female mice were placed in a cage with one normal male mouse 
overnight. Noon on the day when a copulation plug was observed was considered 
day 0.5 of pregnancy. Embryos were collected on embryonic day 11.5 (E11.5) or 
embryonic day 13.5 (E13.5) separately. Eight pregnant mice were injected 
intraperitoneally with 5-bromo-2-deoxyuridine (BrdU) (100μg/g body weight, 
Sigma, USA), 2 h before the collection of embryos on either E11.5 or E13.5. 
Embryos were collected after Caesarean section of pregnant mice anaesthetized 
with intraperitoneal injection of pentobarbital (80mg/kg body weight), cleaned 
from placental membrane by sharp sterile scissors and stored in 0.1M PBS at 4°C.  
 
3. Histology 
3.1 Fixation of embryos 
Materials 
0.1M phosphate buffer (pH7.4): 
NaH2PO4.H2O   2.76g 
Na2HPO4.2H2O   14.24g 
Deionized H2O was added to make up to 1 liter.  
The pH was adjusted to 7.4 with 1N HCl solution. 
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4% paraformaldehyde (4% PF): 
Paraformaldehyde          4g 
0.1M phosphate buffer (pH 7.4)  100ml 
0.1M phosphate buffer with 30% sucrose: 
       Sucrose        30g 
       0.1M phosphate buffer (pH 7.4) was added to make up to 100ml. 
Procedure 
The fixative used in this study was freshly prepared before use. The 4% PF was 
prepared by dissolving paraformaldehyde powder in 0.1M phosphate buffer (pH 
7.4) on a hot plate. The fixative was then cooled down to room temperature. The 
whole embryos were fixed in 4% PF at 4°C overnight and subsequently 
cryoprotected with 30% sucrose in phosphate buffer at 4°C for 6h. The whole 
embryos were photographed using a stereomicroscope (Leica MZ APO, Germany) 
equipped with a digital camera. Embryos with neural tube defects from diabetic 
mice and normal embryos from non-diabetic mice were used as the experimental 
and control groups respectively. 
3.2. Preparation of silane coated slides 
Materials           
2% silane solution:  
Silane       2ml 
Absolute alcohol   98ml 
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Procedure 
The slides were first cleaned by soaking in absolute alcohol for 2 min and 
air-dried. Dried slides were soaked in the silane solution for 2 min and then rinsed 
with distilled water for 2 times. The slides were air-dried at room temperature and 
stored in a 37ºC oven. 
3.3. Cryosection of embryos 
Embryos with neural tube defects from diabetic mice and normal embryos from 
non-diabetic mice were mounted on a metal chuck using M-1 embedding matrix 
(Lipshaw; Pittsburgh, USA) and quickly frozen by immersing in liquid nitrogen. 
Transverse sections of 30μm thickness were cut using a cryostat (Leica CM 3050; 
Leica Microsystems, Germany), mounted on silane coated slides and then allowed 
to dry at room temperature for 2h. 
3.4. Hematoxylin and Eosin staining 
Materials  
      Hematoxylin & Eosin 
    Serially diluted alcohol and xylene 
      Permount mounting medium (Cat. No. SP15, Fisher Scientific, USA) 
Procedure 
For morphological studies, the tissue sections were stained with hematoxylin and 
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eosin.  Frozen sections were rinsed in deionized water before staining with 
hematoxylin for 10 min at room temperature. Differentiation was achieved by 
dipping the mounted sections in acidified 70% ethanol (containing hydrochloric 
acid).  The sections were then washed in deionized water and counter-stained 
with aqueous eosin for 5 min. Finally, the sections were dehydrated in an 
ascending series of alcohol and passed through xylene before being mounted with 
Permount.   
For counting the number of epithelial cells in choroid plexus, four embryos 
from control and three embryos from diabetic mice were used. In each embryo, at 
least two sections cut through the cranial neural tube containing the choroid 
plexus were examined and the number of epithelial cells was scored under the 
light microscope fitted with a digital camera (BX51, Olympus, Tokyo, Japan). 
 
4. RNA isolation and quantification  
Principles 
RNA was isolated using RNeasy mini kit (Qiagen, Germany). This technology 
utilizes the selective binding properties of a silica-gel-based membrane as well as 
the speed of microspin technology. RNA longer than 200 bases binds to the 
silica-gel membrane by a specialized high-salt buffer system. Cells or tissues are 
lysed in a highly denaturing buffer with guanidine isothiocyanate (GITC) which 
rapidly inactivates RNases to ensure the integrity of RNA. Ethanol is added to 
CHAPTER 2: MATERIALS AND METHODS               
46 
make proper binding conditions, and then the extract of homogenized sample is 
loaded to an RNeasy mini column to let the total RNA bind to the membrane. 
Contaminants efficiently are washed off from the sample extract by short spin. 
High-quality RNA is then eluted from the membrane in RNase-free water. With 
this procedure, all RNA molecules longer than 200 nucleotides are purified while 
most RNAs shorter than 200 nucleotides, such as 5.8S rRNA, 5S rRNA, and 
tRNAs, are selectively excluded. 
Materials 
RNeasy mini kit     (Cat. No. 74106, Qiagen, Germany) 
β-Mercaptoethanol   (Cat. No. 63689, Fluka, USA) 
Spectrophotometer   (Eppendorf, Germany) 
10X MOPS buffer 
MOPS                    41.8 g 
DEPC-treated H2O          700 ml 
The pH was adjusted to 7.0 with 2 N NaOH  
1 M sodium acetate          20 ml 
0.5 M EDTA (pH 8.0)        20 ml 
The volume was made up to 1 liter with DEPC-treated H2O 
1X MOPS buffer 
10X MOPS buffer           100 ml 
DEPC-treated H2O           900 ml 
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RNA loading solution 
Formaldehyde                       45µl 
Formamide                         45µl 
10X MOPS buffer                     5µl 
EB (10mg/ml)                       3.5µl 
0.1M EDTA (pH 7.5)                 1.5µl 
Bromophenol blue dye (in 50% glycerol)   8µl 
Procedure 
The cranial neural tube containing the forebrain, midbrain and hindbrain was 
dissected out by cutting the neural tube below the level of caudal hindbrain (Fig 
1A, B) using a surgical scalpel under a stereomicroscope, rapidly frozen in liquid 
nitrogen and stored at -80ºC. Total RNA was extracted from the cranial neural 
tubes in embryos from diabetic and normal mice using the RNeasy mini kit 
according to the manufacturer’s instruction. Neural tubes were lysed in 700µl of 
RNeasy Lysis Buffer (RLT) with 7µl β-Mercaptoethanol (β-ME). The lysate was 
homogenized using a homogenizer and mixed with 700µl of 70% ethanol. The 
mixture was added into a RNeasy mini spin column, and then centrifuged at 
13,000rpm for 15 sec. The flow-through was discarded. Buffer RW1 (700µl) was 
added to the column and centrifuged again at 13,000rpm for 15 sec. The flow 
through was discarded. RPE (500µl) was added to wash the column by 
centrifugation at 13,000rpm for 15 sec. Finally, the tube with column was 
centrifuged at 13,000rpm for 1 min and the flow through was discarded. To elute 
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the total RNA, the RNeasy column was transferred to a new 1.5ml collection tube 
and 30µl of water (RNase free) was added directly to the membrane in the column. 
The tube was allowed to stand for a min and then centrifuged for 1 min at 
13,000rpm.  
The concentration and purity of the extracted RNA were evaluated at 260 nm 
and 280 nm using a spectrophotometer (Eppendorf, Germany). A value within the 
range of 1.9-2.1 was considered an acceptable degree of purity. The integrity of 
the extracted RNA was determined by electrophoresis on a denaturing agarose gel. 
Mini-gel box, gel tray and combs were washed with deionized water. 1.2g of 
agarose was added to 87.5ml of deionized water and heated in a microwave oven 
for 2 min. After the agarose solution was cooled down, 5 ml of 10X MOPS buffer 
and 7.5ml of 12.3M formaldehyde was added into the agarose solution in a 
fume-hood. The solution was poured onto a gel-tray and allowed to solidify for 1h 
at room temperature. Solid gel was submerged in a gel box with 1X MOPS buffer. 
1µg of the extracted RNA was added in 10ul RNA loading solution and then 
heated at 70ºC for 10 min. The RNA sample was rapidly chilled on ice for 1 min 
and then loaded into gel. The denaturing gel was run at 50V until the 
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5. Microarray analysis 
Principles 
DNA microarrays provide a platform to analyse thousands of genes at once in 
nucleic acid samples (Michael and Patrick, 1999). In general, microarray 
experiment involves some basic steps as follows: first, RNA was extracted from 
biological samples; secondly, the RNA is in vitro transcripted, while incorporating 
either fluorescent nucleotides or a tag that is later stained with fluorescence; and 
thirdly, the labelled RNA is hybridized to its corresponding strand spotted on 
microarray. Finally the microarray is scanned under laser light and analyzed. 
 
5.1. Synthesis of double stranded DNA from total RNA 
Materials 
GeneChip® One-Cycle cDNA Synthesis Kit (Cat. No. 900431, Affymetrix, USA) 
includes: 
T7-(dT)24 primer  5’-GGCCAGTGAATTGTAATACGACTCACTAT 
AGGGAGGCGG-(dT)24 - 3’            (50µM) 
SuperScript II Reverse Transcriptase      (200U/µl) 
5X First-strand cDNA buffer 
E. coli DNA ligase                    (10U/µl) 
E. coli DNA polymerase I               (10U/µl) 
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RNase H                            (2U/µl) 
T4 DNA polymerase                   (5U/µl) 
     5X second strand buffer  
dithiothreitol (DTT)                    (0.1M)  
dNTP mix                            (10mM)     
     EDTA                                (0.5M)        
     RNase free water    
Procedure 
First-Strand cDNA synthesis 
2µl of T7-(dT)24 primer, 5.0µg of RNA and variable DEPC treated water were 
mixed in 1.5ml of RNase free polypropylene tube and incubated at 70°C for 
10min in a water bath. The tube was centrifuged briefly at about 10,000 rpm for 
10s and placed on ice. 4 µl of 5X first-strand cDNA buffer, 2µl of 0.1M DTT, and 
1µl of 10mM dNTP were added in the tube and mixed well. The mixture was 
incubated at 42°C for 2min. 1µl of SuperScript II Reverse Transcriptase (200U/µl) 
was added, mixed well by pipetting and incubated at 42°C for 1h. Subsequently, 
the tube was centrifuged briefly at about 10,000 rpm for 10s and placed on ice.  
Second-Strand cDNA synthesis 
30µl of 5X second-strand reaction buffer, 3µl of 10mM dNTP mix, 1µl of 10U/µl 
E. coli DNA ligase, 4µl of 10U/µl DNA polymerase I, 1µl of 2U/µl RNase H, and 
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91µl of DEPC treated water were added to the first strand cDNA synthesis 
reaction. The mixture was incubated at 16°C for 2h. 2µl of T4 DNA polymerase 
(5U/µl) was then added into the tube, mixed well and incubated for 5min. The 
reaction was terminated by adding 10µl of 0.5M EDTA. 
5.2. cDNA cleanup and precipitation 
Materials 
GeneChip Sample Cleanup Module (Cat. No. 900371, Affymetrix, USA) 
Includes:   cDNA cleanup spin columns  
cDNA binding buffer 
cDNA wash buffer, 6 ml concentrate  
cDNA elution buffer  
Fragmentation buffer, 5X 
Collection tubes, 1.5ml, 2ml 
Procedure 
600µl of cDNA binding buffer was added to the synthesized cDNA and the 
mixture was transferred into a cDNA cleanup spin column placed in a 2ml 
collection tube. The tube was centrifuged at 13,000rpm for 1min and the 
flow-through was discarded. Then the spin column was washed with 750µl of 
cDNA wash buffer by centrifuging at 13,000rpm for 1min. Finally, the spin 
column was centrifuged for 5min with column cap open. To elute the cDNA, 14µl 
of cDNA elution buffer was added directly onto the column membrane and the 
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spin column was centrifuged at 13,000rpm for 1min. 
5.3. Synthesis of Biotin-labeled cRNA  
Materials 
GeneChip® IVT Labeling Kit (Cat. No. 900449, Affymetrix, USA) includes:  
10X reaction buffer 
Biotin-labeled ribonucleotides (dNTPs with Bio-UTP and Bio-CTP) 
IVT Labeling Enzyme Mix 
20X T7 RNA polymerase (Cat. No. 2085, Ambion, USA) 
Procedure 
12µl of sample cDNA, 4µl of 10X reaction buffer, 12µl of biotin-labeled 
ribonucleotides, 4µl of IVT Labeling Enzyme Mix, 1µl of 20X T7 RNA 
polymerase, and nuclease-free water to provide a final reaction volume of 40µl 
were added to a 1.5ml RNase free tube. The tube was briefly vortexed, centrifuged, 
and then incubated at 37°C for 5h. After that, the tube was immediately chilled on 
ice to terminate the reaction. 
5.4. cRNA cleanup and quantification 
Materials 
RNeasy mini kit     (Cat. No. 74106, Qiagen, Germany) 
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5X Fragmentation Buffer:   
In an RNase-free Falcon tube, the followings were mixed thoroughly and 
filtered through a 0.2μm vacuum filter. 
1M Tris-acetate, pH 8.1 (adjusted with glacial acetic acid)    4.0 ml 
Magnesium Acetate (MgOAc)                         0.64 g 
Potassium Acetate (KOAc)                            0.98 g 
DEPC-treated water to final volume                     20mL 
Procedure 
cRNA cleanup using Qiagen RNeasy mini kit 
First, the volume of in vitro transcription (IVT) product was adjusted to 100µl 
with RNase free water. Then 350µl of buffer RLT was added and mixed 
thoroughly by pipetting up and down. Subsequently, an additional 250µl of 100% 
ethanol was added and mixed thoroughly. The mixture was transferred to a mini 
spin column and centrifuged at 13,000rpm for 15 sec. The column was washed by 
buffer RPE twice and transferred to a new RNase free vial. Finally, 50µl of RNase 
free water was added directly to the membrane in the column and centrifuged for 
1min at 13,000rpm to elute the purified cRNA. 
 
Quantification of the cRNA (IVT Product)  
RNA yield was determined spectrophotometrically. The ratio of the absorbance at 
260nm/280nm was maintained between 1.9 and 2.1 for the purity of RNA. For 
quantification of cRNA, an adjusted cRNA yield was calculated to reflect 
carryover of unlabeled total RNA using a formula given below:  
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Adjusted cRNA yield = RNAm - (total RNAi)(y) 
RNAm = amount of cRNA measured after IVT (µg) 
Total RNAi = starting amount of total RNA (µg) 
y = fraction of cDNA reaction used in IVT (in this study, y=1) 
5.5. Fragmentation of the cRNA for target preparation 
Hybridization of the cRNA targets to Gene chips is improved if the cRNA size is 
fragmented to 35 to 200 bases using metal-induced hydrolysis at high temperature. 
15µg of the purified cRNA was mixed with 6µl of 5X fragmentation buffer in a 
tube and the reaction was made up to 30ul with RNase free water. The mixture 
was incubated at 94°C for 35min and then immediately cooled down to 4°C. The 
fragmented sample RNA was stored at -20°C.  
5.6. Target hybridization 
Materials 
GeneChip Eukaryotic Hybridization Control Kit (Cat. No. 900299, 
Affymetrix) includes: Control oligonucleotide B2, 3nM & Eukaryotic 
hybridization control, 20X  
Herring sperm DNA  (Cat. No. D1811, Promega) 
Acetylated bovine serum albumin (BSA), 50 mg/ml (Cat. No. 15561020, 
Invitrogen)  
Hybridization buffer, 1X, 2X  
Mouse Expression Array 430A and 430A 2.0 
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Procedure 
10µg of fragmented cRNA was mixed with 3.3µl of 3nM control oligonucleotide 
B2, 10µl of 20X eukaryotic hybridization control, 2µl of 10 mg/ml herring sperm 
DNA, 2µl of 50mg/ml acetylated BSA, 100µl of 2X hybridization buffer, and 
nuclease-free water to provide a final volume of 200µl, incubated at 99°C for 
5min and subsequently incubated at 45°C for 5min. The insoluble material was 
removed by centrifuging at 13,000rpm for 5min. Meanwhile, the probe array was 
filled with 160µl of 1X hybridization buffer and incubated at 45°C for 10min. 
After removing the buffer, the probe array was filled with 130µl of hybridization 
mixture and incubated in the oven heated to 45°C for 16h. 
5.7. Post-hybridization washing, staining and scanning of arrays 
Materials and Equipments 
 
GeneChip® Scanner 3000              (Cat. No. 00-00212, Affymetrix, USA) 
GeneChip® Fluidics Station 450         (Cat. No. 00-0079, Affymetrix, USA) 
Wash Buffer A (non-stringent wash buffer)  (Cat. No. 900721, Affymetrix, USA)  
Wash Buffer B (stringent wash buffer)      (Cat. No. 900722, Affymetrix, USA) 
 
SAPE stain solution 
2X MES Stain Buffer                         600µl 
acetylated BSA (50mg/ml)                      48µl 
(Cat. No. 15561-020, Invitrogen, USA)  
 
SAPE (1mg/ml)                              12µl 
(Cat. No. S-866, Molecular Probes, USA) 
DEPC-treated water                       to 1200µl 
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Antibody solution 
2X MES Stain Buffer                          300µl 
acetylated BSA (50mg/ml)                       24µl 
(Cat. No. 15561-020, Invitrogen, USA)  
 
normal goat IgG (10mg/ml)                       6µl 
(Cat. No. I-5256, Sigma, USA) 
 
biotinylated anti-Streptavidin antibody (0.5mg/ml)   3.6µl 
(Cat. No. BA-0500, Vector Labs, USA)  
DEPC-treated water                         to 600µl 
Procedure 
After 16h of hybridization, the hybridization cocktail was removed and 160µl of 
non-stringent wash buffer was filled into probe array. Bubbles were carefully 
removed to avoid hybridization background. The fluidics protocol for antibody 
amplification started with two post hybridization washes, 10 cycles of 2 mixes 
with non-stringent wash buffer at 30°C and 6 cycles of 15 mixes with stringent 
wash buffer at 50°C. Subsequently three stain protocol was used. First, each array 
was stained with 600µl of streptavidin-phycoerythrin (SAPE) solution for 5min at 
35°C. Then the arrays were washed with non-stringent wash buffer (10 cycles of 4 
mixes) at 30°C. 600µl of antibody solution was used in second stain for 
amplifying signals. 600µl of SAPE solution was used again in third stain. Finally 
the arrays were washed with non-stringent wash buffer (15 cycles of 4 mixes) at 
35°C. When the protocol was finished, the arrays were filled with non-stringent 
wash buffer and temperature was maintained at 25 °C. Care was taken to make the 
arrays free of bubbles for proper scanning.  
Arrays were scanned once under 570nm wavelength with 3um pixel value in 
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a GeneChip® Scanner 3000 according to Affymetrix protocol. Scanned output 
image files (.dat) were analyzed with GeneChip® Operating Software (GCOS). 
Arrays were scaled globally to an average intensity of 500 and analyzed 
independently. 
Microarray data quality was assessed using Affymetrix guidelines. The 
boundaries of the probe area were identified by the hybridization of the B2 
oligonucleotide which serves as a positive hybridization control and was used by 
the software to place a grid over the image. The hybridization controls were added 
into the hybridization samples and were used to evaluate sample hybridization 
efficiency on the arrays. β-actin and GAPDH were used to assess RNA sample 
and assay quality. Specifically, the signal values of the 3’ probe sets for β-actin 
and GAPDH were compared to the signal values of the corresponding 5’ probe 
sets. The ratio of the 3’ probe set to the 5’ probe set is generally not more than 3 
for the 1-cycle assay. 
5.8. Data analysis 
5.8.1. Absolute data analysis 
In single array analysis which is also called the absolute analysis, .chp file is 
created using .cel image file. The image file is automatically generated from .dat 
file by Affymetrix Gene Chip Operating Software (GCOS). Single array analysis 
acts as a launch pad by providing initial dataset required to perform comparison 
analysis. This dataset is considered as baseline if it is used as the control and as 
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the experiment if it is treated. 
5.8.2. Comparison data analysis 
In comparison analysis, two samples are compared against each other in order to 
detect and quantify changes in gene expression (Chen, 2007). In our present study, 
comparison files were generated from cel file by GCOS for each group, using 
control as the baseline and treated as the experiment. 
5.8.3. Gene filtration 
The following criteria were set for determining which genes were differentially 
expressed between diabetic and control groups. Firstly, all of the measurements on 
each chip were divided by the 50th percentile value (per chip normalization). 
Secondly, each gene was normalized to the baseline value of the control sample 
(per gene normalization) using median. Genes from "all genes" with expression 
control signal from 75 to 18,872 in at least 3 of 6 conditions were selected. Genes 
‘Present’ or ‘Marginal’ in at least 3 of 6 samples were then selected. The genes 
were filtered using the "Filter on Fold Change" option in GeneSpring software. A 
minimum 1.5 fold change in gene expression defined differential expression for 
this data set. 
5.8.4. Gene clustering and functional analysis based on Gene Ontology 
Genes filtered by the above criteria were subjected to agglomerative 
average-linkage hierarchical clustering with Gene Spring 7.3 software (Agilent, 
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CA, USA) using standard correlation as similarity matrix. Further data mining for 
functional classification of genes based on Gene Ontology (GO), which is widely 
accepted as the standard for describing the biological process, molecular function 
and cellular component for genes was carried out using DAVID (The Database for 
Annotation, Visualization and Integrated Discovery). 
 




Reverse transcription combined with polymerase chain reaction (RT-PCR) is a 
technique to purposely amplify the number of copies of a specific region of DNA. 
The process of PCR includes denaturing, annealing and synthesis of DNA, which 
are repeated for 30 to 40 cycles. During these processes, the double strand of the 
sample DNA is heated to open as a single stranded DNA which is then hybridized 
with a set of 5’ and 3’ end primers, short fragments of DNA that are designed to 
base pair to a specific region of single stranded sample DNA (Mullis and Faloona, 
1987). RT-PCR is currently the most sensitive technique for mRNA detection and 
quantitation in compared to the two other commonly used techniques such as 
Northern blot analysis and RNase protection assay. RT-PCR can be used to 
quantify mRNA levels from much smaller samples and even from a single cell. 
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Real time RT-PCR 
The real time RT-PCR is a recent advanced quantitative RT-PCR technology with 
high sensitivity. Real time RT-PCR incorporates a DNA-binding fluorescent dye, 
such as SYBR green I, which binds in the minor groove of double-stranded DNA, 
to detect and quantify the PCR product after each cycle of the reaction (Morrison 
et al., 1998). In the process of DNA denaturing, the dye is unbound and exhibits 
very little fluorescence in the reaction system. When DNA is extended, the 
fluorescent dye intercalates into the newly formed double-stranded DNA, 
resulting in an increase in the fluorescence signal. Thus, the increase in 
fluorescence intensity at the end of the extension step of every PCR cycle is 
directly proportional to the increase in amount of amplified DNA. After a few 
cycles of PCR, the fluorescent signal of the PCR product is measured to be 
statistically significant above background signal. This point is described as 
threshold cycle (Ct), which occurs during the exponential phase of PCR cycle 
(Gibson et al., 1996). In addition, the specificity of the amplification can be tested 
by a melting curve of the PCR product (Ririe et al., 1997). DNA melts at a 
specific temperature called the melting temperature (Tm). The melting 
temperature of a DNA depends on its GC/AT ratio, therefore the DNA that has 
more GC base pairs have a higher Tm than those rich in AT base pairs. 
Fluorescent dye is released upon melting of the double stranded DNA, providing 
accurate Tm data for every single amplified product, thus desired products can be 
distinguished from undesirable products, such as primer dimers.  
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Data analysis of real time RT-PCR 
There are two kinds of Real time RT-PCR data analysis, absolute quantification 
and relative quantification. The absolute quantification determines the copy 
number of the target transcript by relating the PCR signal to the standard curve. 
The relative quantification determines the change in gene expression level of 
experimental samples relative to another set of untreated controls or samples at 
time zero in a time-course study (Livak and Schmittgen, 2001). In addition, the 
target gene is normalized with an endogenous reference gene for the relative 
quantification. Housekeeping genes and non-regulated genes like 
glyceraldehydes-3-phosphate dehydrogenase (GAPDH), albumin, actin, tubulin, 
cyclophilin, 18S rRNA and 28S rRNA are frequently used as the reference genes 
(Marten et al., 1994; Thellin et al., 1999).  
The 2-ΔΔCt method (Livak and Schmittgen, 2001) was used in this study to 
analyze the real time RT-PCR data and determine the relative changes in gene 
expression. The data are calculated as the fold change of target gene expression 
normalized to an endogenous reference gene, relative to a calibrator. For the 
treated samples, evaluation of 2-ΔΔCt indicates the fold change of gene expression 
relative to the untreated control. For this method to be valid, the amplification 
efficiencies of the target and reference must be approximately equal.  
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Materials  
Oligo (dT) primer (Cat. No. C1101, Promega, USA) 
dNTP (Cat. No. U1240, Promega, USA) 
RNase inhibitor  (Cat. No. N2111, Promega, USA) 
Molony Murine Leukemia Virus Reverse Transcriptase (M-MLVRT) with 
5X Reaction buffer  (Cat. No. M1701, Promega, USA)   
LightCyclerTM-FastStart DNA Master SYBR Green I (Cat. No. 
03515869001, Roche, Germany)  
LightCyclerTM real time PCR machine (Roche, Germany)   
Primers of target genes (Table 2) 
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103 60/10 72/5 
5’-ccttcgactcttcctcctttg-3’      
NM_013697 Ttr 
5’-gacagcatccaggactttgac-3’ 
112 60/10 72/5 
5’- tctccttatcccaagcacctt-3’     
NM_010514 Igf2 
5’-ttctccttgggttctttcacc-3’ 
138 60/10 72/5 
5’- tccagtcagcaaaggtaagga-3’   
NM_010025 Dcx 
5’-ccaagagagaacagcaaacca-3’ 
146 60/10 72/5 
5’- gcctcagactcagccactatg-3’    
NM_007523 Bak1 
5’- gagtgaaggtggggttcaagt-3’ 
146 60/10 72/5 
5’- ccagggctagacgaagagaat-3’  
NM_011249 Rbl1 
5’- cacatctggcttgaacttgtg-3’ 
104 60/10 72/5 
5’- agctaaggttacccacgaacc-3’  
NM_009760 Bnip3 
5’- caaaactgaccacccaaggta-3’ 
















124 60/10 72/5 
NM_010431 Hif-1α 
5’-aggaagctagggctgaaacaa-3’   
5’-gccatgtaccagaatcaaacc-3’ 
127 60/10 72/5 
NM_001025250 Vegf 
5’-gtccaacttctgggctcttct-3’     
5’-ttccttctcttcctcccctct-3’ 
























135 60/10 72/5 
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Procedure 
Synthesis of cDNA  
The synthesis of cDNA was carried out in a total volume of 25µl reaction mix 
containing 2µg of total RNA, 2.5µmol/l of Oligo(dT) primer, 200U of M-MLVRT, 
2mmol/l of each dNTPs, 5U of RNase inhibitor and RNase free water. Initially, 
2µg of RNA with 1µl Oligo(dT) primer was heated at 70ºC for 5min in a 
microcentrifuge tube to denature the template. Then the tube was chilled on ice 
and other components were added in the reaction. The mixture was incubated at 
42ºC for 1h and the reaction was stopped by heating for 5 min at 95 °C. 
The real time RT-PCR     
Based on the probe sequences information from Affymetrix NETAFFY analysis 
center (https://www.affymetrix.com/analysis/netaffx/), primers were designed 
using Primer 3 software (http://frodo.wi.mit.edu/). The primer sequence and PCR 
thermal profiles are listed in Table 2. The reaction mix (20µl) containing 5µl of 
cDNA, 4µl of LightCycler FastStart DNA MasterPLUS SYBR Green I master mix, 
1µl (0.5µM) of each primer and 9µl of PCR grade water was pre-incubated at 95 
°C for 10 min. Subsequently, the PCR was performed with 45 cycles of 
denaturation at 95 °C for 15sec, annealing at temperatures corresponding to the 
genes (Table 2) and elongation at 72 °C for PCR product size/25sec. The 
expression level of specific gene was quantified, expressed as Ct, the cycle number 
at which the LightCycler System first recorded the upstroke of the exponential 
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phase of PCR product amplification, and normalized by the level of β-actin 
expression in each individual sample (Livak and Schmittgen, 2001). 
 
7. Immunohistochemistry (IHC) 
Principles 
Immunohistochemistry (IHC) is a widely-used method for localizing target 
proteins in tissues or cells using the principle of antigen-antibody specific binding. 
A series of technical developments in IHC has created various sensitive detection 
systems, including the enzyme-conjugated system, such as peroxidase conjugated 
system, for light microscope; the electron-dense particles-labeled system for 
electron microscope; and the fluorescent dye-tagged system, such as FITC, Cy3, 
Rhodamine labeled system, for fluorescence or confocal laser scanning 
microscopy. 
IHC on tissue sections is routinely performed with the following steps: 
fixation, blocking, incubation with primary antibody and detection of the primary 
antibody. Fixation of tissue is required to stabilize and protect the tissues or cells 
from rigors of subsequent processing and staining. Blocking of nonspecific 
background staining enhances the specificity of the primary antibody. Antibody 
molecules are labeled or flagged to permit their visualization.  
The detection system can be divided into direct conjugate-labeled antibody 
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method and indirect conjugate-labeled antibody method. The direct method is a 
one-step staining method in which the labeled antibody binds directly to the target 
antigen in tissues. In the indirect method, the primary antibody that is raised 
specifically against the target antigen is added to the sample, followed by addition 
of the labeled secondary antibody, which has specificity against an antigenic 
epitope present on the primary antibody. Thus, the secondary antibody serves to 
label the primary antibody, which, in turn, is bound to the antigen in tissue. The 
indirect method is frequently used since the signal could be amplified through 
several secondary antibody reactions with different antigenic sites on the primary 
antibody. 
Materials 
0.1M phosphate-buffered saline (PBS): 
            Di-sodium hydrogen phosphate heptahydrate         13.3g 
Sodium chloride                                8.5g 
      Distilled water to make up to 1000ml 
The pH was adjusted to 7.4 with 1N hydrochloric acid (HCl) in the 
solution. 
 
0.1M PBS containing 0.1% Tween-20 (PBST): 
Tween-20            1ml 
0.1M PBS           1000ml 
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0.05M Tris buffered saline (TBS; pH 7.6): 
Tris base (Trihydroxymethylaminomethane)     6g 
Sodium chloride                           8g 
Distilled water to make up to 1000ml 
The pH was adjusted to 7.6 with 1N hydrochloric acid (HCl) in the 
solution. 
0.1% ammonium nickel sulphate Tris buffered saline (TBS; pH 7.6): 
Ammonium nickel sulphate                  1g 
TBS                                   1000ml 
3,3’  diaminobenzidine tetrahydrochloride (DAB) solution: 
DAB                                   50mg 
30% hydrogen peroxide                  33µl  
TBS                       100ml 
0.3% Hydrogen Peroxide (0.3% H2O2): 
33% Hydrogen Peroxide                     1ml 
0.1M PBST                             100ml 
      Permount mounting medium (Cat. No. SP15, Fisher Scientific, USA) 
Procedure  
Frozen sections mounted on silane coated slides were air dried for 2h. The slides 
were rinsed for 30min in 0.1% PBST solution. Sections were treated with 0.3% 
H2O2 to inhibit endogenous peroxidase activity. Sections were then blocked by 
5% normal serum derived from host species of secondary antibodies for 1h, and 
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subsequently incubated with the respective primary antibodies at the proper 
dilution overnight at room temperature. Details of the various primary antibodies 
used are listed in Table 3. After incubation with the primary antibodies, tissue 
sections were rinsed with 0.1% PBST 3 times for about 15min and incubated with 
biotinylated secondary antibodies for 1h at room temperature. Details of the 
secondary antibodies used are list in Table 3. The sections were rinsed with PBS, 
and incubated with Avidin-Biotin complex (ABC reagent, Vector Lab., USA) for 
1h. Immunostaining was visualized with DAB (Sigma, USA) as the peroxidase 
substrate. The reaction product was intensified with 0.1% ammonium nickel 
sulphate. The tissue sections were finally counter-stained with 1% methyl green, 
dehydrated in graded concentrations of alcohol and xylene and coverslipped with 
Permount. 
Table 3: List of primary and secondary antibodies used for immunohistochemistry 
Antibody Name Dilution Host Company 
Catalogue 
No 
Primary antibody     
anti-transthyretin 1:100 Goat 
Santa Cruz Biotechnology, 
USA 
SC8104 
anti-insulin like growth 
factor 2 
1:100 Rabbit 
Santa Cruz Biotechnology, 
USA 
SC5622 
Secondary antibody     
biotinylated anti-goat IgG 1:200 Rabbit Vector Lab, USA BA5000 
biotinylated anti-rabbit IgG 1:200 Goat Vector Lab, USA BA1000 
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8. Immunofluorescence staining 
Materials 
Mouse IgG blocking reagent (Vector Laboratories) 
4’, 6- diamidino-2-phenylindole dihydrochloride (DAPI) (Molecular Probes, USA) 
Fluorescent Mounting Medium (Cat. No. S3023, Dako, Denmark) 
0.1M phosphate-buffered saline (PBS) 
0.1M PBS containing 0.1% Tween-20 (PBST) 
Procedure 
Frozen sections mounted on saline coated slides were air dried for 2h. The slides 
were rinsed for 30min in 0.1% PBST solution. Sections were then blocked by 5% 
normal serum derived from host species of secondary antibodies for 1h, and 
subsequently incubated with the primary antibodies at the appropriate dilution 
overnight at room temperature. Dilution factor for the various primary antibodies 
used are listed in Table 4. Subsequently, sections were washed with 0.1% PBST 
and incubated with Cy3-conjugated anti-rabbit IgG for Blbp staining and 
biotinylated anti-guinea pig IgG for doublecortin (Dcx) staining (Table 4) for 1h 
at room temperature. For Dcx staining, the sections were incubated with 
Fluorescein Avidin D for 1h at room temperature. Finally, sections were 
counterstained with DAPI (1µg/ml) for 5min, and mounted with fluorescent 
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mounting medium. The photo-images were captured using an Olympus FV1000 
confocal microscope. 
Table 4: Primary and Secondary antibodies used for immunofluorescence staining  
Antibody Name Dilution Host Company 
Catalogue 
No 
Primary antibody     
anti-doublecortin  1:5000 guinea pig Chemicon, USA AB5910 
anti-brain lipid binding protein 1:3000 rabbit Chemicon, USA AB9558 
Secondary antibody     
Cy3-conjugated anti-rabbit IgG 1:200 sheep Sigma, USA C2306 
biotinylated anti-guinea pig IgG 1:200 goat Vector Lab, USA BA7000 
Immunofluorescence     
Fluorescein Avidin D 1:300  Vector Lab, USA A2001 
 
9. BrdU labeling analysis 
Principles 
5-bromo-2-deoxyuridine (BrdU) is a synthetic thymidine analog that gets 
incorporated into DNA strands of proliferating cells during the S-phase of the cell 
cycle. Specific antibody against BrdU can be used to visualize the incorporated 
BrdU in the cell immunohistochemically. Denaturation of the DNA by exposing 
the cells to acid or heat is required to facilitate the binding of the antibody. The 
proliferation index of the cells in a tissue section is analyzed by quantifying the 
percentage of BrdU positive cells. 
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Materials 
5-bromo-2-deoxyuridine (BrdU) (Cat. No. B5002, Sigma, USA) 
Mouse anti-BrdU monoclonal antibody (Cat. No. B2531, Sigma, USA) 
Cy3-conjugated goat anti-mouse IgG (Cat. No. AP181C, Chemicon, USA) 
Mouse IgG blocking reagent (Cat. No. PK2200, Vector Lab., USA) 
biotinylated anti-mouse IgG (Cat. No. BA2000, Vector Lab., USA) 
Avidin-Biotin complex (ABC reagent) (Cat. No. PK4002, Vector Lab., 
USA) 
Diaminobenzidine (DAB) (Cat. No. D8001, Sigma, USA) 
4’, 6- diamidino-2-phenylindole dihydrochloride (DAPI) (Cat. No. D1306, 
Molecular Probes, USA) 
Fluorescent Mounting Medium (Cat. No. S3023, Dako, USA) 
0.1M phosphate-buffered saline (PBS) 
0.1M PBS containing 0.1% Tween-20 (PBST) 
Permount (Cat. No. SP15, Fisher Health Care, USA) 
Procedure  
Pregnant mice from the control and diabetic groups (n=3 in each group) were 
injected intraperitoneally with BrdU (100µg/g body weight) 2 h before the 
collection of embryos by Caesarean section. The whole embryos were fixed in 4% 
PF at 4°C overnight and cryoprotected with 30% sucrose in phosphate buffer at 
4°C for 4h. Embryos with neural tube defects from diabetic mice and normal 
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embryos from non-diabetic mice were used as the experimental and control 
groups respectively. Transverse sections of 30μm thickness through cranial neural 
tubes of the embryos were cut using a cryostat (Leica CM 3050, Leica 
Microsystems, Germany).  
Immunofluorescence labeling was carried out for the localization of BrdU 
positive cells in the neural tube of E11.5 embryos. Sections were rinsed in PBST, 
treated with 2N HCl at 37ºC for 30 min, blocked with mouse IgG blocking serum 
for 1h, and incubated with mouse anti-BrdU monoclonal antibody (1:500) 
overnight at room temperature. Subsequently, sections were incubated with 
Cy3-conjugated goat anti-mouse IgG (1:200) for 1h. Finally, sections were 
counter-stained with DAPI (1µg/ml) and mounted with Fluorescent Mounting 
Medium. Photo-images of the sections were captured in a confocal microscope 
(Olympus FV1000, Olympus, Japan).  
Immunohistochemistry labeling was carried out for the localization of BrdU 
positive cells in choroid plexus epithelium in cranial neural tubes of E13.5 
embryos. After rinsed in PBST, sections were treated with 2N HCl at 37ºC for 
30min. Then sections were blocked with mouse IgG blocking serum for 1h and 
incubated with mouse anti-BrdU monoclonal antibody (1:500) overnight at room 
temperature. Subsequently, sections were incubated with biotinylated anti-mouse 
IgG (1:200) for 1h at room temperature. The sections were rinsed with PBS and 
incubated with Avidin-Biotin complex for 1h. Immunostaining was visualized 
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with DAB as a peroxidase substrate. The reaction product was intensified with 
0.1% ammonium nickel sulphate. The tissue sections were finally counter-stained 
with 1% methyl green, dehydrated in graded concentrations of alcohol and xylene 
and mounted with Permount. 
The number of BrdU-positive cells in the cranial neural tube was quantified 
using a total of 12 sections (one each from the telencephalon, diencephalon, 
rhombencephalon and choroid plexus of each embryo) from 3 embryos of each 
group (control and diabetic). The percentage of BrdU-positive cells was calculated 
in relation to the total number of cells in the neuroepithelium of diabetic and 
control mouse embryos. Results were expressed as mean ± SE of the percentage 
of BrdU positive cells.   
 
10. Terminal Deoxynucleotidyl Transferase -mediated dUTP Nick-End 
Labeling analysis (TUNEL) 
Principles 
Apoptosis is the most common form of programmed cell death and is essential in 
many processes, such as cancer and embryogenesis. Inappropriate regulation of 
apoptosis may play an important role in many pathological conditions including 
brain diseases (Ceccatelli et al., 2004; Johnson, Jr. and Deckwerth, 1993; 
Oppenheim et al., 1999). In general, apoptotic cells display a characteristic pattern 
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of structural changes in nucleus and cytoplasm, including rapid blebbing of 
plasma membrane and nuclear disintegration which is associated with extensive 
chromatin damage and fragmentation of DNA. During apoptosis, DNAse activity 
generates double-stranded, low-molecular-weight DNA fragments (mono- and 
oligonucleosomes), and introduces strand breaks ("nicks") into the 
high-molecular-weight DNA. The process of DNA fragmentation can be identified 
by labeling the free 3-OH termini of DNA nick ends with fluorescein-dUTP using 
the enzyme, Terminal deoxynucleotidyl Transferase (TdT), which attaches labeled 
nucleotides to all 3OH-ends. Labeling with fluorescein is followed by 
immunohistochemical detection using anti-fluorescein-specific antibodies that are 
conjugated to horse-radish peroxidase or alkaline phosphatase. Apoptotic cells can 
be visualized using the substrate DAB in a light microscope. This method is very 
sensitive and widely used for detection of apoptosis (Gavrieli et al., 1992).  
Materials 
In situ cell death detection kit (Cat. No. 11684817910, Roche, Germany) 
0.1M phosphate-buffered saline (PBS) 
0.1M PBS containing 0.1% Tween-20 (PBST): 
4% paraformaldehyde (PF) 
3, 3’ diaminobenzidine tetrahydrochloride (DAB) solution 
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Procedure 
Detection of apoptosis in the cranial neural tube of embryos from diabetic and 
control mice by TUNEL was carried out with an in situ cell death detection kit 
according to the manufacturer’s instruction. Frozen sections mounted on silanized 
slides were air dried for 2h and then washed twice with PBS. The sections were 
fixed with freshly prepared 4% PF for 20 min at room temperature, washed with 
PBS for 30 min, incubated with 3% H2O2 in methanol for 10 min and then 
permeabilized with PBST for 2min on ice. Subsequently, the sections were 
incubated with TUNEL reaction mixture containing the TdT and 
fluorescein-labeled nucleotides for 60min at 37ºC in a humidified box in the dark. 
The section were rinsed 3 times with PBS and then incubated with anti-fluorescein 
antibody conjugated with horseradish peroxidase for 30min at 37°C. Finally, the 
reaction products were visualized with DAB. The sections were counter-stained 
with Haematoxylin and the TUNEL-positive cells were examined under a light 
microscope (BX51, Olympus, Japan) at 20X magnification. 
 
11. In situ Hybridization 
Principles 
In situ hybridization is widely used to determine the spatial expression pattern of a 
gene. This involves applying a labeled antisense RNA probe, complimentary 
nucleotide sequence to the mRNA of the gene of interest, either to tissue sections 
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or to whole-mount specimens. Labeled probes are prepared by incorporating 
radioisotopes or non-reactive digoxigenin (DIG)-dUTP into nucleic acids. The 
labeled probes can be detected by autoradiography or anti-DIG IgG which is 
usually conjugated with alkaline phosphatase. Since there are several drawbacks 
in using radiolabeled probes, including long exposure time, rapid radioactive 
decay leading to a limited visualization window, and disposal problems associated 
with radioactive material, currently non-reactive DIG-labeled probes have been 
widely used. This method was originally described by Hemmati-Brivanlou’s 
group (Hemmati-Brivanlou et al., 1990) and then modified by various groups.  
 
11.1. Plasmids for preparation of cRNA probes 
Plasmids containing cDNA of paired box gene 6 (Pax6) and neurogenin 2 (Ngn2) 
were kindly provided by Dr. Guillermo Oliver (St. Jude Children's Research 
Hospital, Tennessee, USA) and Dr. Francois Guillemot (The National Institute for 
Medical Research, London, UK), respectively. 
 
11.2. Preparation of competent cells 
Materials 
TFB1 solution: 
RbCl2    1.2g 
MnCl2.4H2O  0.99g 
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CaCl2    0.15g 
Glycerol   15.0g 
3M KAc   1ml 
The solution was made up to 100 ml with sterilized water. The pH 
was adjusted to 5.8 by glacial acetic acid. 
TFB2 solution: 
0.5M MOPS  2ml 
RbCl2    0.12g 
CaCl2.2H2O  1.1g 
Glycerol   15.0 g 
The solution was made up to 100ml with sterilized water. The pH 
was adjusted to 6.8 with NaOH. 
Luria-Bertani (LB) medium: 
Trypton  10g 
Yeast extract 5g 
NaCl   10g 
H2O   1L 
LB medium was purchased from the NUMI store of the National 
University of Singapore. 
Procedure 
XL Blue strain cells of E. Coli taken from -80ºC freezer were spread on the 
pre-warmed LB plate and incubated at 37ºC overnight. The next day, a single 
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clone was transferred into 5ml of LB medium and shaken at 250rpm in an orbital 
shaker (Forma, USA) at 37ºC overnight. The culture was transferred to 250ml of 
LB at 37ºC, and shaken at 250rpm till the OD reached 0.6 (λ=600). The cells were 
centrifuged at 3500rpm for 10min at 4ºC. The pellet was resuspended in 50ml of 
ice cold TFB1 solution, incubated on ice for 5min, and then centrifuged at 
3500rpm for 10min at 4ºC. The pellet was resuspended again in 10ml of TFB2 
solution and incubated on ice for 30min. Finally, the cells were aliquoted as 100µl 
per vial, rapidly immersed into liquid nitrogen, and stored in -80ºC freezer. 
11.3. Transformation of competent cells with plasmid 
Materials 
Plasmid mini and midi kits (Cat. No. 12123 and 12143, Qiagen, Germany) 
Procedure 
100ng of plasmid of Pax6 or Ngn2 was added into 100µl of competent cells and 
incubated on ice for 30min. Cells were heat shocked at 42ºC for 90 sec and then 
chilled on ice for 2min. Then, 500µl of LB was added into each tube, which was 
shaken in an orbital shaker at 200rpm, 37ºC for 1h. The cells were dispersed and 
striped evenly on LB plate (with ampicillin) and incubated at 37ºC with the lid 
facing up for 5 min and then incubated with the lid facing down overnight. 
Five colonies were selected and each of them was transferred into a separate 
tube containing 5ml of LB with 100µg/ml ampicillin, and the tubes were shaken at 
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250rpm, 37 ºC overnight in an orbital shaker. Cells from 2ml of E. coli culture 
were harvested and the plasmids were extracted using a plasmid mini kit (Qiagen, 
Germany). The plasmid incorporation was confirmed with restriction enzyme 
analysis.    
1ml of E. coli culture made from confirmed single colony was inoculated in a 
flask containing 100ml of LB with 100µg/ml of ampicillin and shaken at 250rpm, 
37ºC overnight. The cells were harvested and the recombinant plasmids were 
extracted using a plasmid midi kit according to manufacturer’s instruction.  
Generally, the Qiagen plasmid purification technique involves an alkaline 
lysis procedure, followed by binding of plasmid DNA to anion-exchange resin 
under appropriate low salt and pH conditions. RNA, proteins, dyes and 
low-molecular-weight impurities were washed off by a medium-salt buffer and 
then the plasmid DNA was eluted in a high-salt buffer. Finally, the plasmid DNA 
was concentrated and desalted by isopropanol precipitation. 
11.4. Linearization of the plasmid 
Materials 
BamHI restriction enzyme (Cat. No. R6021, Promega, USA) 
Tris-saturated phenol (pH 8.0) 
4M Lithium chloride (LiCl) 
70% ethanol 
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100% ethanol 
RNase free water 
      TE buffer (pH8.0)            10ml  
           1M Tris  pH8.0        1ml 
           H2O                  9 ml 
           0.5 M EDTA           20ul 
Procedure 
Plasmids were linearized with specific restriction enzyme (BamHI for Pax6 and 
Ngn2). Restriction digests were performed at 37ºC for 2h in a 100µl reaction 
containing 5µg of plasmid DNA with 25 Units of restriction enzyme and 1X 
buffer. The linearized DNA was loaded onto 0.8% low melting agarose gel. The 
band containing the linearized DNA was cut from the gel on the UV 
transilluminator and weighed. Equal volume of TE buffer was added to the gel in 
the tube and kept at 55ºC for 5min till the gel was liquefied. Equal volume of 
Tris-saturated phenol (pH 8.0) was added into the tube and mixed well. The tube 
was centrifuged at 12000rpm for 10min at 4ºC and the aqueous phase was 
transferred into a new tube. One tenth volume of ice cold 4M LiCl and 2.5 volume 
of ice cold 100% ethanol was added into aqueous phase and kept in -80ºC for 1h. 
After centrifugation at 12000rpm for 15min and washing the pellet with 70% 
ethanol, the pellet of linearized plasmid DNA was dried and dissolved in RNase 
free water.  
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11.5. Synthesis of digoxigenin-labeled RNA probe from the linear DNA 
Materials   
DIG RNA labeling mix (Cat. No. 1277073, Roche Applied Science, 
Germany)  
T3 RNA polymerase (Cat. No. 600111, Stratagene, USA) 
T7 RNA polymerase (Cat. No. 600123, Stratagene, USA) 
RNase inhibitor     (Cat. No. N2111, Promega, USA) 




70% & 100% ethanol 
Procedure 
The reaction mixture containing 1µg of linear DNA, 2µl of 10X Reaction buffer, 
2µl of Dig RNA labeling mix, 1µl of T3 (for Pax6) or T7 (for Ngn2) RNA 
polymerase, 1µl of RNase inhibitor and RNase-free water (make up to total 
volume of 20µl) was incubated at 37ºC for 2h. At the end of incubation, 2µl of 
DNase I was added and incubated at 37ºC for 15min to remove template DNA. 
The reaction was stopped with 2µl of 0.2M EDTA. RNA transcripts were 
precipitated with 0.1 volume of 4M LiCl and 2.5 volume of ice cold 100% ethanol 
at -80ºC for 1h. After centrifugation at 12000rpm at 4ºC for 15min and washing 
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the pellet with ice cold 70% ethanol, the pellet of the precipitated RNA transcripts 
was dried, dissolved in RNase-free water and stored at -80ºC. 
 
11.6. Whole mount in situ hybridization  
Materials 
DEPC treated Water: 
H2O            1000ml 
DEPC            1ml 
Stirred overnight and autoclaved 
20X SSC 
NaCl               87.6g 
Sodium citrate        44.1g 
DEPC-H2O was added up to 500ml and pH was adjusted to 7.0. 
50mg/ml Heparin           
            Heparin (Cat. No. H3400, Sigma, USA)    50mg          
            H2O                                 1ml 
10mg/ml yeast tRNA    
            yeast tRNA (Cat. No. R6625, Sigma, USA)  10mg 
            H2O                                  1ml 
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prehybridization solution 
Boehringer Block          0.5 g  
Formamide               25 ml 
20X SSC (pH 7)           12.5 ml 
heated to 65°C for about 1h. Once dissolved, followings were added:  
10mg/ml yeast tRNA        5ml 
50mg/ml Heparin           100 µl 
20% Tween-20             250 µl 
10% CHAPS               500 µl 
0.5 M EDTA               500 µl 
H2O                      6 ml 
Hybridization solution 
Prehybridization solution          500µl 
0.1µg/µl DIG-labelled RNA Probe   5µl 
            Heated at 95ºC and chilled on ice for 5 min before use. 
Maleic Acid Buffer (MAB) 
Maleic acid   11.6g 
NaCl         8.8g 
DEPC-H2O was added up to 1L and pH was adjusted to 7.5 with 
1N NaOH.  
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10% boehringer blocking reagent 
Boehringer block (Cat. No. 11096176001, Roche, Germany)     1g 
PBST                                               10ml 
Blocking antibody buffer 
Goat serum                         1ml 
10% Boehringer blocking reagent        1ml 
PBST                              8ml 
The mixture was heated at 65 °C until total dissolution, filtered through 
4.5 micron filters, and chilled on ice.  
Preabsorbed AP-anti-Digoxygenin Antibody 
AP-anti-Digoxygenin antibody (Cat. No. 1093274, Roche, Germany) 3µl 
Antibody buffer                                          15ml 
The above solution was rocked at 4ºC for 2h  
Alkaline phosphatase (AP) buffer: 
1M Tris, pH9.5  1ml 
       1M MgCl2    0.5ml 
       5M NaCl    0.2ml 
       Tween 20    10µl 
       DEPC water was added up to 10ml. 
Proteinase K (Cat. No. 03 115 836 001, Roche, Germany) 
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BM purple (Cat. No. 11 442 074 001, Roche, Germany) 
3-[(3-Cholamidopropyl) dimethylammonio]-1-propanesulfonate (CHAPS)  
(Cat. No. C-3023, Sigma, Germany) 
Procedure 
Preparation of mouse embryos 
The embryos were dissected free of extra embryonic membranes and fixed in 
freshly prepared 4% PF at 4°C overnight. The next day the embryos were washed 
in PBST (PBS with 0.1% Tween-20) twice for 10min each. Then the embryos 
were dehydrated with a methanol series in PBST (25%, 50%, 75% and 100%) and 
stored in 100% methanol at -80°C for further use.   
 
Hybridization 
The embryos were rehydrated through 75%, 50% and 25% methanol series in 
PBST. The embryos were washed 3 times with PBST for 5min each, bleached by 
incubating with 6% H2O2 for 1hr, and washed 3 times with PBST again for 5min 
each. Then the embryos were treated with 5µg/ml of proteinase K in PBST for 
15min and the reaction was stopped by washing in freshly prepared 2mg/ml 
glycine in PBST. After washed 2 times with PBST for 5min each, the embryos 
were refixed with fresh 4% PF + 0.2% glutaraldehyde in PBST for 15min, and 
washed with PBST 3 times for 10min each. Prehybridization of embryos was 
carried out with 1ml of prehybridization solution at 65ºC for 3h. For hybridization, 
the prehybridization solution was replaced with hybridization solution containing 
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1µg/ml digoxigenin-labelled RNA probe, and the embryos were incubated at 70ºC 
overnight.  
 
Post-hybridization washes and antibody incubation 
After hybridization, the embryos were washed with 800µl of prehybridization 
solution for 5min at 70°C. Then the embryos were washed three times with 
addition of 400µl of 2X SSC, each time without removing prehybridization 
solution. After removing the solution, the embryos were washed twice in 2X SSC 
with 0.1% CHAPS at 70 °C for 30 min each. The embryos were washed in Maleic 
acid buffer (MAB) twice at room temperature for 10 min each and at 70 °C for 30 
min twice. After washed in PBST 3 times for 5 min each, the embryos were 
preblocked in 1ml blocking antibody buffer for 2h at 4°C with rocking. The 
embryos were incubated with preabsorbed anti-Digoxygenin-AP antibody 
overnight at 4°C with rocking. 
 
Post-antibody washes and color development 
The next day, embryos were washed 6 times with 0.1% BSA in PBST for 45min 
each to remove nonspecific staining. After washed in PBST twice for 30 min each, 
the embryos were washed again in AP buffer at room temperature twice for 10min 
each. Then embryos were incubated with 1ml BM purple in a dark chamber till the 
color developed to the desired extent. The staining reaction was stopped by 
washing in PBS with several frequent changes. After staining, embryos were fixed 
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in 4% PF.  
The whole mount embryos were photographed using a stereomicroscope 
equipped with camera (Leica MZ APO, Germany). Some embryos were sectioned 
(30µm) using the cryostat (Leica CM 3050, Germany) and the sections were 
photographed using Olympus X51 light microscope (Olympus, Japan).  
 
12. Western blot analysis 
Principles 
Western blot (or immunoblot) is a commonly used method to detect and determine 
the relative amount of specific proteins in tissue homogenate or extract (Towbin et 
al., 1979). Firstly, protein samples are extracted from tissues or cells using 
assorted detergents, salts, and buffers which help lysis of cells and solubilize 
proteins. Protease and phosphatase inhibitors are also added into the homogenate 
to prevent the degradation of the sample by its own enzymes. Secondly, the 
mixture of protein is separated on a gel by electrophoresis. Polyacrylamide gels 
and buffers with sodium dodecyl sulfate (SDS) are the most common type of gel 
electrophoresis. SDS-PAGE (SDS polyacrylamide gel electrophoresis) maintains 
polypeptides in a denatured state once they are denatured with strong reducing 
agents to break their secondary and tertiary structure (e.g. S-S disulfide bonds to 
SH and SH) which allows separation of proteins by their molecular weight. After 
separation, proteins are transferred to a membrane which can be either 
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nitrocellulose or polyvinylidene fluoride (PVDF). Primary antibodies are used to 
detect specific protein antigens on the membrane. Detection of antibody-antigen 
immune complexes on a membrane is accomplished using secondary antibodies 
covalently conjugated with horseradish peroxidase (HRP) enzyme. The 
chemiluminescence of HRP substrate is developed on a standard X-ray film.  
Materials 
Protease inhibitor cocktail kit (Cat. No. 78410, Pierce, USA) 
Mammalian protein extraction reagent (Cat. No. 78503, Pierce, USA) 
Protein assay kit (Cat. No. 5000002, Bio-Rad, USA) 
10% resolving gel: 
H2O       7.9ml 
       30% acrylamide mix   6.7ml 
1.5 M Tris (pH 8.8)  5.0ml 
       10% SDS       0.2ml 
       10% ammonium persulfate 0.2ml 
       Tetramethylethylenediamine (TEMED)          0.008ml 
5% stacking gel: 
H2O           5.5ml 
       30% acrylamide mix  1.3ml 
1.0 M Tris (pH 6.8)      1.0ml 
       10% SDS          0.08ml 
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       10% ammonium persulfate 0.08ml 
       TEMED          0.008ml 
 
1x SDS gel-loading buffer: 
50mM Tris.Cl (pH 6.8) 
       100mM dithiothreitol 
       2% SDS 
       0.1% bromophenol blue 
       10% glycerol 
Tris-glycine electrophoresis buffer: 
25mM Tris 
       250mM glycine 
       0.1% SDS 
Transfer buffer: 
25mM Tris 
       250mM glycine 
       20% Methanol 
1X TBS: 
        Tris base   2.42 g 
        NaCl    0.8 g 
        Made up to 1L with H2O; pH was adjusted to 7.6 with 2N HCl 
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1X TBST: 
        1X TBS 1 liter 
        0.1% Tween 20 
Mouse anti-Hif1α monoclonal antibody (Cat. No. MAB5382, Chemicon, 
USA) 
Rabbit anti-Vegf polyclonal antibody (Cat. No. SC-152, Santa Cruz, USA) 
Goat anti-rabbit IgG conjugated with horseradish peroxidase (Cat. No. 
7074, Cell Signaling Technology, USA) 
Mouse anti-β-actin monoclonal antibody (Cat. No. A1978, Sigma-Aldrich, 
USA) 
Goat anti-mouse IgG conjugated with horseradish peroxidase (Cat. No. 
31430, Pierce, USA) 
SuperSignal West Pico Chemiluminescent Substrate (Cat. No. 34080, 
Pierce, USA)  
96 well plate (Cat. No. 3860-096, Asahi Techno Glass, Japan) 
Procedure 
Protein extracts from cranial neural tube of individual embryo from control and 
diabetic mice were prepared separately using protein extraction reagent, which 
was added with protease inhibitor cocktail and EDTA solution. Briefly, the cranial 
neural tube was lysed with 600µl of protein extraction reagent in a homogenizer. 
The supernatant was collected by centrifugation at 13,000g at 4ºC for 15min and 
stored at -20ºC. The concentration of protein extracts was determined using a 
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protein assay kit. Four different concentrations (0.5, 0.25, 0.125, and 0.0625mg/ml) 
of BSA were prepared as protein standards. 10µl of each standard or sample and 
200µl of dye reagent were added together to each well of a 96-well plate, mixed 
thoroughly and incubated at room temperature for 10min. The absorbance of 
protein standard or sample was measured at 595nm using a microplate reader 
(GENios, Tecan, Switzerland). The concentration of protein extract was 
determined according to the standard curve of BSA. 
Aliquots of protein extracts (10µg each) were heated to 95ºC for 5min in 5x 
SDS gel-loading buffer to denature the proteins before the proteins were separated 
by 10% SDS-PAGE. Next, the proteins were transferred from the gel to the 0.2µm 
PVDF membranes using a semi-dry electrophoretic transfer cell (Bio-Rad, USA). 
Membranes were washed with TBST buffer and then blocked with 5% non-fat 
milk in TBST for 1h at room temperature. Subsequently, the membranes were 
incubated with mouse anti-Hif1α antibody (1:100) or rabbit anti-Vegf antibody 
(1:200) overnight at 4ºC in a shaker. The next day, blots were incubated with 
secondary anti-mouse IgG antibody (1:10000) or anti-rabbit IgG antibody 
(1:10000) conjugated with horseradish peroxidase for 1h at room temperature. 
Equal amount of protein loading was confirmed by reprobing the membrane with 
anti- β-actin mAb (1:5000). Immunopositive bands were visualized by 
chemiluminescent substrate, and quantified by scanning densitometer and 
Quantity One software, version 4.4.1 (Bio-Rad, USA). 
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1. Neural tube defects in embryos of diabetic mice 
It is well demonstrated that maternal diabetes induces congenital malformations in 
various organs including neural tube during development. Neural tube defects 
(NTDs) are one of the common anomalies in embryos of diabetic mice in this 
study. About 12% of embryos (E11.5) from diabetic mice (n=20) showed neural 
tube malformations, including excencephaly, syntencephaly and spina bifida as 
reported previously (Liao et al., 2004). The exencephalic phenotype is 
characterized by defect in closure of the forebrain, midbrain and hindbrain (Fig. 
1A, B). 
Histological analysis of transverse sections of different parts of the cranial 
neural tube including the telencephalon (tc), diencephalon (dc) and 
rhombencephalon (rc) from E11.5 embryos of control and diabetic mice clearly 
demonstrated the cranial neural tube malformations with varying degrees of 
severity in embryos of diabetic mice (Fig 2A-D). The neuroepithelia of 
telencephalon, diencephalon and rhombencephalon from embryos of diabetic mice 
were distinctly distorted and their walls were fused, leaving the ventricular system 
including lateral ventricles (LV), third ventricle (III) and fourth ventricle (IV), 
collapsed (Fig 2A-D). The size and volume of the ventricles appeared to be 
reduced markedly in comparison to that of embryos from normal pregnancies. 
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2. Gene expression profile of cranial neural tubes in embryos of control and 
diabetic mice 
In order to gain insights of molecular basis for morphological changes in the 
cranial neural tube of embryos with NTDs derived from diabetic mice, gene 
expression profile of the cranial neural tubes in E11.5 embryos of control and 
diabetic mice was established by microarray analysis. The microarray analysis 
was carried out using the Affymetrix oligonucleotide chip which helped to 
compare global gene expression patterns of the cranial neural tubes of E11.5 
embryos from control and diabetic mice. 
Overall, 1613 genes have been found to be differentially expressed with the 
magnitude of more than 1.5 folds change in the developing brain of E11.5 
embryos from diabetic mice as compared to that of embryos from control mice. 
These genes were hierarchically clustered using GeneSpring v7.3 (Agilent, CA, 
USA) (Fig 3).  
Among these genes, a total of 390 genes exhibited greater than 2-folds of 
change with a cluster of 180 genes (46.2%) showing increased expression and the 
rest (53.8%) showing decreased expression in the cranial neural tubes of embryos 
from diabetic pregnancies. According to the Gene Ontology Consortium database 
for biological processes [http://www.geneontology.org/], these genes have been 
placed into 8 main functional categories as follows (Fig 4): (1) metabolism 
(27.7%); (2) cellular physiological process (20.3%); (3) cell communication 
(12.1%); (4) morphogenesis (6.9%); (5) response to stimulus (3.8%); (6) cell 
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death (2.3%); (7) cell differentiation (2.1%); (8) small subsets of genes (5.4%). 
About 19.4% of genes that were differentially expressed had no known functional 
annotations. Microarray results were validated by the real time RT-PCR for 
selected genes (Table 5).   
 
3. Effect of maternal diabetes on expression of genes involved in glucose 
metabolism and that respond to physiological hypoxia in cranial neural tubes 
of mouse embryos  
Embryonic dysmorphogenesis in diabetic pregnancies appears to be the result of 
multiple causes including the maternal metabolic abnormalities. Microarray 
analysis revealed that the expression of genes that are involved in pathways 
related to glucose metabolism and that respond to physiological hypoxia was 
altered in embryos of diabetic pregnancies. 
 
3.1. Maternal diabetes altered the expression of genes involved in glycolysis in 
cranial neural tubes of mouse embryos  
Expression of majority of the genes involving glycolysis pathway was found to be 
upregulated in cranial neural tubes of embryos from diabetic mice (Table 6 and 
Fig 5). Expression of some of these genes (hk1, hk2, pfkl, pfkp, pkm2 and ldh) 
which encode key enzymes of the glycolysis pathway has been validated by the 
real time RT-PCR (Fig 6). The results obtained by RT-PCR confirmed the 
microarray results.  
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3.2. Maternal diabetes altered the expression of genes that respond to hypoxia in 
cranial neural tubes of mouse embryos 
Expression of genes that respond to hypoxia was also upregulated in cranial neural 
tubes of embryos from diabetic mice (Table 6). For example, hypoxia-inducible 
factor 1α (Hif-1α) was found to be upregulated in cranial neural tube of embryos 
from diabetic mice. Hif-1α plays a key role in the adaptive response to hypoxia, 
transactivating many genes whose protein products are involved in pathways of 
angiogenesis, glucose metabolism and cell proliferation (Semenza, 2003). 
Morever, the upregulation of Hif-1α transactivates antiproliferative and 
proapoptotic genes (Bacon and Harris, 2004). The expression of Igfbp3 and P21, 
which are regulated by Hif1α and negatively regulate the cell proliferation and cell 
cycle (Feldser et al., 1999; Goda et al., 2003), was found to be upregulated. In 
addition, Bnip3, which is a hypoxically inducible gene and a proapoptotic member 
of BCL2 family (Sowter et al., 2001) was also found to be upregulated.  
 
3.2.1. Expression of hypoxia-inducible factor 1α (Hif1α) in cranial neural tubes of 
embryos from control and diabetic mice 
Microarray analysis showed the increased expression of Hif1α gene in cranial 
neural tubes of E11.5 embryos from diabetic mice in comparison to that of control 
mice (Table 6). This result was further confirmed by the real time RT-PCR which 
showed upregulation of Hif1α mRNA expression in cranial neural tubes of E11.5 
embryos derived from diabetic mice (Fig 7). The Hif1α protein was detected in 
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cranial neural tubes of E11.5 embryos from control and diabetic mice by western 
blot (Fig 8A). Quantitative analysis showed that the Hif1α protein level was 
increased in cranial neural tubes of embryos from diabetic mice when compared to 
that of embryos from control mice (Fig 8B). This change in the Hif1α protein 
expression correlated well with the change in the Hif1α mRNA expression in 
cranial neural tubes of embryos from diabetic mice. 
 
3.2.2. Expression of Vegf in cranial neural tubes of embryos from control and 
diabetic mice 
Hypoxia induces angiogenesis as a compensatory mechanism to supply adequate 
oxygen by inducing several angiogenic factors including vascular endothelial 
growth factor (Vegf) (Mazure et al., 1996; Plate et al., 1992). Vegf is considered 
as a key regulator of angiogenesis particularly during embryogenesis (Breier et al., 
1992; Dumont et al., 1995; Millauer et al., 1993). Analyses by both microarray 
(Table 6) and real time RT-PCR (Fig 9) showed that expression of Vegf gene was 
significantly increased in cranial neural tubes of embryos from diabetic mice. In 
addition, the protein expression of Vegf has also been analyzed in cranial neural 
tubes of embryos from control and diabetic mice (Fig 10A). The quantity of Vegf 
expression was significantly increased in cranial neural tubes of embryos from 
diabetic mice, compared to that of embryos from control mice (Fig 10B). This 
change in the Vegf protein expression was comparable with the change in the Vegf 
mRNA expression in cranial neural tubes of embryos from diabetic mice.  
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4. Maternal diabetes induces apoptosis in the neuroepithelium of cranial 
neural tubes in mouse embryos 
It has been previously shown that maternal diabetes induces apoptosis in the 
neural tube of mouse embryos (Fine et al., 1999; Phelan et al., 1997). Microarray 
analysis in the present study revealed that the expression levels of a majority of 
the genes that regulate apoptosis including proapoptotic genes such as 
transformation related protein 53 (p53), BCL2/adenovirus E1B 19 kDa interacting 
protein 3 (Bnip3) and BH3 interacting domain death agonist (Bid) were increased 
in cranial neural tubes of embryos from diabetic mice (Table 7). 
TUNEL analysis further showed that numbers of apoptotic cells were 
markedly increased in the neuroepithelia of forebrain (including the telencephalon 
and diencephalon) and rhombencephalon in embryos from diabetic mice, in 
comparison to that of embryos from normal mice (Fig 11). 
 
5. Maternal diabetes inhibits proliferation index in the neuroepithelium of 
cranial neural tubes in mouse embryos 
The proliferation index in cranial neural tubes of E11.5 embryos from diabetic and 
normal mice was examined by immunohistochemical detection of BrdU 
incorporation (Fig 12A-D). The transverse sections through the telencephalon, 
diencephalon and rhombencephalon of cranial neural tubes from embryos of 
diabetic mice were compared with that of embryos from normal mice. 
Immunofluorence staining showed that the percentage of BrdU labeled cells was 
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significantly decreased in neuroepithelia of telencephalon (40.6%±3.2% vs. 
63.7%±4.1%, p<0.001), diencephalon (29.7%±1.6% vs. 53.7%±8.3%, p<0.02) 
and rhombencephalon (37.1%±3.7% vs. 45.2%±4.3%, p<0.05) of embryos from 
diabetic mice in comparison to that of embryos from normal mice (Fig 12E). 
 
6. Maternal diabetes alters the expression of genes involved in neuronal 
migration and neurogenesis in cranial neural tubes of mouse embryos 
It is well established that the survival, proliferation and differentiation of 
neuroepithelial cells of different regions of the brain are controlled by several 
developmental control genes during embryogenesis. The microarray analysis 
showed that several genes involved in proliferation, migration and differentiation 
of neuronal and glial cells in the cranial neural tube were differentially expressed 
in embryos of diabetic mice (Table 8). The expression levels of a majority of the 
genes which control neuronal migration and neurogenesis including the 
microtubule-associated proteins such as doublecortin (Dcx), and doublecortin-like 
kinase (Dclk), neurogenic differentiation 1 (Neurod1), neurogenin 2 (Ngn 2), 
Notch signaling pathway genes such as Notch gene homolog 1 (Notch 1) and 
hairy and enhancer of split 6 (Hes 6), brain lipid binding protein (Blbp), 
insulin-like growth factor-2 (Igf-2), paired box gene 6 (pax6), bone morphogenetic 
protein 4 (Bmp4), etc were downregulated in cranial neural tubes of embryos from 
diabetic pregnancies, indicating an impaired neurogenesis and neuronal migration 
in embryos of diabetic pregnancy.  
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6.1. Expression pattern of developmental control genes is altered in embryos of 
diabetic mice 
 
6.1.1. Paired box gene 6 (Pax6) 
Pax6, a paired box transcription factor with key functional roles in the developing 
brain, promotes neuronal differentiation via transcriptional regulation of the Ngn2 
gene (Scardigli et al., 2003). Microarray analysis showed that expression of Pax6 
was downregulated in cranial neural tubes of embryos from diabetic pregnancy 
(Table 8). The real time RT-PCR analysis further confirmed the decreased mRNA 
expression level of Pax6 in cranial neural tubes of embryos from diabetic mice 
compared to that of embryos from control mice (Fig 13). By in situ hybridization 
analysis, the mRNA expression of Pax6 was localized to the forebrain including 
the telencephalon and diencephalon in embryos of control mice (Fig 14A-C). 
However in the forebrains of embryos from diabetic pregnancies, the expression 
level of Pax6 appeared to be markedly decreased and its expression domain was 
distinctly perturbed (Fig 14D-F).  
 
6.1.2. Neurogenin 2 (Ngn2) 
Ngn2, a proneural gene belonging to family of the bHLH factors, is expressed in 
the distinct progenitor populations in the nervous system and is involved in the 
specification of neuronal phenotype in the developing brain (Parras et al., 2002). 
Microarray analysis revealed that expression of Ngn2 was downregulated in 
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cranial neural tubes of embryos from diabetic mice (Table 8). The downregulation 
of Ngn2 in cranial neural tubes of embryos from diabetic mice compared to that of 
embryos from control mice was further confirmed by the real time RT-PCR 
analysis (Fig 15). In situ hybridization analysis revealed the mRNA expression 
pattern of Ngn2 in the forebrain including the telencephalon and diencephalon, 
and rhombencephalon in embryos of control mice (Fig 16A-D). Its expression 
level seemed to be markedly decreased and the expression domain was distinctly 
perturbed in both telencephalon and diencephalon of embryos from diabetic mice 
(Fig 16E-G). However, the expression level of Ngn2 appeared to be unaffected in 
the rhombencephalon of embryos from diabetic mice compared with the control 
(Fig 16D, H). 
 
6.2. Development of radial glial cell lineages and migration of neurons are 
disrupted in the cranial neural tubes of embryos from diabetic mice 
 
6.2.1. Doublecortin (Dcx) 
Doublecortin (Dcx), a microtubule-associated protein, is expressed in migrating 
neuroblasts and differentiating young neurons throughout the central and 
peripheral nervous system during embryonic development (Couillard-Despres et 
al., 2001; des, V et al., 1998; Gleeson et al., 1998). Consistent with microarray 
results showing down-regulation of Dcx (Table 8), the domain containing Dcx 
positive cells was found to be markedly decreased in the forebrain and 
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rhombencephalon in cranial neural tubes of embryos derived from diabetic mice 
when compared to that of embryos from control mice (Fig 17A-D).  
 
6.2.2. Brain lipid binding protein (Blbp) 
During early development, migration of cells in the neural tube occurs along the 
radial glial cells, which serve as neuronal progenitors, neuronal migration guides 
and astrocyte progenitors (Malatesta et al., 2003; Noctor et al., 2001; Parnavelas 
and Nadarajah, 2001). Blbp is expressed in the radial glial cells which are also 
essential for maintenance of neuroepithelial cells during early cortical 
development (Arai et al., 2005). As observed in microarray analysis (Table 8), 
immunofluorescence analysis also revealed that the domains containing Blbp 
positive cells in the neuroepithelia of telencephalon, diencephalon and 
rhombencephalon were attenuated in embryos of diabetic mice (Fig 17A-D). In 
addition, the processes of Blbp-positive radial glial cells extending towards pial 
surface appeared to be disrupted in the neuroepithelia of embryos from diabetic 
pregnancies (Fig 17E, F). Further, Neurofibromatosis type 1 (Nf-1) which has 
been shown to downregulate Blbp (Miller et al., 2003) was upregulated in cranial 
neural tubes of embryos from diabetic pregnancies (Table 8), indicating that 
downregulation of Blbp is possibly mediated via upregulation of Nf-1 in cranial 
neural tubes of embryos from diabetic pregnancy. 
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7. Development of choroid plexus is impaired in cranial neural tubes of 
embryos from diabetic mice 
The choroid plexus (CP) is found in the developing brain at three sites of cerebral 
ventricles, the lateral ventricle (LV), the 3rd ventricle (III) and the 4th ventricle (IV). 
It is composed of a single layer of epithelial cells around the mesenchymal tissue 
containing blood vessels. In the present study, CP was hardly detectable in any of 
the ventricles at E11.5 embryos although it was reported to be developed as early 
as E10 in the 4th ventricle. However, it was readily evident in the IV of cranial 
neural tubes in embryos at E13.5 (Fig 18A, C and E). In addition, the CP was 
found to be poorly developed or absent in the IV of E13.5 embryos from diabetic 
mice (Fig 18B, D, and F). Quantitative analysis revealed that the number of 
epithelial cells was significantly decreased in the CP of embryos from diabetic 
mice compared to that of embryos from control mice (Fig 19). The volume of IV 
appeared to be markedly reduced in embryos of diabetic mice (Fig 18B, D). 
The CP produces the cerebral spinal fluid (CSF) which provides an essential 
expanding mechanism that determines the shape of the brain during its 
development (Dziegielewska et al., 2001) and several growth factors such as 
transthyretin (Ttr) and insulin-like growth factor-2 (Igf-2).  
 
7.1. Transthyretin (Ttr) 
Ttr is the major protein synthesized by the CP epithelial cells and is involved in 
the transport of thyroxine and retinol from the peripheral circulation to the brain 
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(Dickson et al., 1987; Ferguson et al., 1975; Raz et al., 1970). The microarray 
analysis showed the decreased expression of Ttr in E11.5 embryos of diabetic 
mice, in comparison to that of control mice (Table 5). This result was further 
confirmed by the real time RT-PCR which showed downregulation of Ttr in 
cranial neural tubes of both E11.5 and E13.5 embryos derived from diabetic mice 
(Fig 20).  
Immunohistochemical analysis of Ttr was carried out in cranial neural tubes 
of E11.5 and E13.5 embryos from control and diabetic mice. Ttr appeared to be 
weakly expressed in the tela choroidea, the developmental forerunner of the 
choroid plexus, in the cranial neural tubes of E11.5 embryos from control mice 
(Fig 21A), whereas in E13.5 embryos of control mice, the expression of Ttr was 
clearly evident in the epithelial cells of the CP (Fig 21C). However, the 
immunostaining of Ttr was markedly reduced in the tela choroidea of E11.5 
embryos and CP epithelium of E13.5 embryos from diabetic mice (Fig 21B, D).  
 
7.2. Insulin-like growth factor 2 (Igf-2) 
Igf-2, a polypeptide hormone which functions as a mitogen during embryogenesis 
and as a morphogen in inducing differentiation of CP epithelial cells during 
development (Cavallaro et al., 1993; Eicher et al., 1993). Expression of Igf-2 was 
decreased in cranial neural tubes of E11.5 embryos from diabetic mice in 
comparison to that of embryos from control mice as shown in the microarray 
analysis (Table 5). The real time RT-PCR analysis also confirmed the 
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downregulation of Igf-2 in cranial neural tubes of E11.5 and E13.5 embryos 
derived from diabetic mice (Fig 22).  
As revealed by immunohistochemistry analysis, the Igf-2 protein expression 
was detectable in the tela choroidea in cranial neural tubes of E11.5 embryos from 
control mice (Fig 23A). Intense immunostaining of Igf-2 was localized to the 
epithelial cells of the CP in cranial neural tubes of E13.5 embryos from control 
mice (Fig 23C). The immunostaining of Igf-2 was absent or markedly reduced in 
the tela choroidea of E11.5 embryos and CP epithelium of E13.5 embryos from 
diabetic mice (Fig 23B, D). 
 
7.3. The proliferation index in the choroid plexus and adjacent neuroepithelia 
The proliferation index in the CP and the adjacent neuroepithelia around the 
ventricles was measured by BrdU labeling in E13.5 embryos of both normal and 
diabetic mice. Mitotic cells in the developing CP were hardly detectable in cranial 
neural tubes of embryos from both normal and diabetic mice. However, the BrdU 
positive cells were detected in the base of the CP and adjacent neuroepithelia 
around the ventricles (Fig 24A, C). The percentage of proliferating cells in 
relation to total cells in the neuroepithelia around the IV and base of the CP was 
significantly decreased (12.9%±1.2% vs. 30.7%±5.1%, p<0.01) in embryos from 
diabetic mice compared to that of embryos from control mice (Fig 24B, D and E). 
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It has been widely demonstrated that the maternal diabetes induces malformations 
in various organs including neural tubes in embryos of rodents and humans 
(Akazawa, 2005; Liao et al., 2004; Mills et al., 1979). Neural tube defects (NTDs) 
in embryos of diabetic pregnancy have been shown to be associated with altered 
expression of some developmental control genes involved in neurulation (Liao et 
al., 2004). More recently, it has been shown that high-glucose concentration alters 
the expression of genes that are involved in proliferation and differentiation of 
neural stem cells (NSCs), indicating the basis for the CNS malformations in 
infants of diabetic mothers (Fu et al., 2006). The present study is the first of its 
kind demonstrating the differential gene expression profiling of cranial neural 
tubes in embryos of diabetic mice in comparison to that of embryos from control 
mice. 
During neurulation in mouse embryos, the neural plate closure occurs at 
E8.5-9.5 and subsequently the rostral end of the neural tube enlarges in size due to 
an increase in the size of ventricles which are filled with CSF secreted by CP 
epithelium (Sturrock, 1979). During this expansion process, progenitor cells in the 
neuroepithelia around the ventricles undergo proliferation, migration and 
differentiation into different types of neurons and glia that form the brain. The 
initial neurulation and subsequent brain development require accurate 
coordination of the proliferation, differentiation and apoptotic cell death of neural 
and glial progenitor cells. These events are mediated by a complex interplay 
between genetic and environment factors, which involve the function of inductive 
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signaling molecules, and thereby activation of transcription factors that control the 
position of different cell types in the developing brain (Harris and Juriloff, 1999). 
Altered expression of many of those genes caused by environmental factors or 
teratogenicity including maternal diabetes appeared to be implicated in neural tube 
anomalies.  
In the present study, malformations were evident in the telencephalon, 
diencephalon, and rhombencephalon as well as the ventricular system of E11.5 
embryos from diabetic mice. In addition, several genes involved in intracellular 
metabolism, cellular physiological process, morphogenesis, apoptosis, 
proliferation and cell differentiation have been found to be differentially expressed 
in cranial neural tubes of embryos from diabetic pregnancy. Although the present 
study does not reveal the molecular mechanisms that contribute to the neural tube 
anomalies, it provides a clue for changes in molecular cues that guide the 
development of different functional regions of the brain after the period when the 
neural tube closure occurs. 
 
1. Apoptotic cells are increased and mitotic index is decreased in cranial 
neural tubes of embryos from diabetic mice.   
Apoptosis which is a key feature in the early rapid expansion phase of neural tube 
development occurs in the neural tube on E10-E11 in order to halt premature 
neurogenesis (Akazawa, 2005). Apoptosis has been shown to be induced markedly 
in the developing brain in the absence of several signaling molecules or factors 
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(Mason et al., 2006; Yu et al., 2002). Recently, downregulation of Pax3 expression 
by maternal diabetes has been shown to be associated with increased apoptosis in 
the mouse neural tube, resulting in neural tube defects (Fine et al., 1999; Phelan et 
al., 1997). The present study also shows a significant increase in the number of 
apoptotic cells in neuroepithelia of the telencephalon, diencephalon, and 
rhombencephalon in E11.5 embryos of diabetic mice. Increased apoptosis was 
further corroborated by microarray results which showed an increased expression 
of several proapoptotic genes including p53, Bnip3 and Bid in cranial neural tubes 
of embryos from diabetic mice (Shaw et al., 1992; Vande et al., 2000; Wang et al., 
1996). The proapoptotic proteins, such as p53, Bnip3 and Bid, induce programmed 
cell death by inhibiting anti-apoptotic proteins, such as Bcl2 and Bcl-XL, which 
may protect immature neurons from death (Boyd et al., 1994). Recently, it has 
been shown that Pax3 inhibition promotes p53-mediated cell death in the neural 
tube, leading to NTD (Pani et al., 2002). Taken together, it appears that maternal 
diabetes alters the expression of developmental control genes which subsequently 
induce the proapoptotic genes, leading to excessive apoptosis in the cranial neural 
tube. 
On the other hand, maternal diabetes seems to impair the mitotic index in 
cranial neural tubes of mouse embryos. It has been shown that exposure to high 
glucose inhibits the cell-cycle progression in neural stem cells, microvessel 
endothelial cells and mesangial cells (Abraham et al., 2003; Fu et al., 2006; Wolf 
et al., 2001). Further, the placental growth has been shown to be delayed due to 
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altered proliferation index in diabetic pregnancies (Weiss et al., 2001). In the 
present study, the decreased proliferation index in cranial neural tubes of embryos 
from diabetic mice was associated with down-regulation of expression of genes 
that are involved in cell proliferation such as Igf2 and Tgfb2. These changes 
suggest that the glucotoxicity caused by maternal diabetes alters the cell cycle 
progression in the cranial neural tube by regulating the expression of genes 
involved in apoptosis and cell proliferation which may subsequently result in 
malformations of the developing brain of embryos from diabetic mice. 
 
2. Expression of genes involved in neuronal migration and differentiation is 
altered in cranial neural tubes of embryos from diabetic mice 
The neural tube originates from a single layer of neuroepithelial cells (Bayer and 
Altman, 1991; Panchision and McKay, 2002). These progenitor cells proliferate 
and then differentiate sequentially into distinct neurons and glia that form 
functional networks in the CNS. Throughout the neurodevelopment, a distinct 
pattern of gene expression specific for neurogenesis and gliogenesis is evident in 
the progenitor cells. Regulation of cell fate specification in the developing brain is 
complex and influenced by both cellular intrinsic factors and extracellular 
environmental cues. Maternal diabetes appears to alter the expression pattern of 
genes that are involved in differentiation and specification of different types of 
neurons and glia. 
Development of mammalian brain substantially depends on migration and 
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axon projection of newborn neurons. Doublecortin (Dcx) encoding 
microtubule-associated protein is expressed in the migrating neurons (Francis et 
al., 1999; Friocourt et al., 2003; Gleeson et al., 1999). Mutations in the human 
DCX gene are associated with abnormal neuronal migration, epilepsy, 
lissencephaly and mental retardation (LoTurco and Bai, 2006). This gene together 
with doublecortin-like kinase (Dclk), a gene that shares high homology with Dcx, 
function in the formation of axonal projections across the midline and in the 
neuronal migration (Bai et al., 2003; Koizumi et al., 2006). Dclk has been further 
shown to control mitotic division by regulating spindle formation and also to 
determine the fate of neural progenitors during neurogenesis (Shu et al., 2006). In 
the present study, downregulation of both Dcx and Dclk mRNA expression and 
decreased number of Dcx immuno-positive cells indicate the disruption of 
neuronal proliferation and migration as well as axonal wiring in cranial neural 
tubes of embryos from diabetic mice. 
 Migration of cells from the ventricular zone in the cranial neural tube occurs 
along the radial glial cells during early stage and through the meshwork of 
astrocyte processes after the formation of astrocytes postnatally (Thomas et al., 
1996). Radial glial cells which are identifiable with a molecular marker, Blbp, a 
member of the fatty acid-binding protein (FABP) family, serve as neuronal 
progenitors and neuronal migration guides as well as astrocyte progenitors (Hatten, 
2002; Hunter and Hatten, 1995; Malatesta et al., 2003; Noctor et al., 2001; 
Parnavelas and Nadarajah, 2001). The differentiation of radial glial cells is 
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regulated by Notch1 signaling through the transcriptional activation of Blbp 
(Patten et al., 2006). Further, Blbp is known to be a downstream gene of Pax6 
transcription factor which promotes neuronal differentiation via transcriptional 
regulation of the Ngn2 (Arai et al., 2005). The maternal diabetes-induced 
downregulation of Notch 1 receptor and Pax6 as well as its downstream genes 
Blbp and Ngn2 in the cranial neural tube indicates the impaired differentiation of 
radial glial cell lineages, neuronal migration and neurogenesis in cranial neural 
tubes of embryos from diabetic mice. However, further study is required to 
determine whether altered expression of these genes contributed to neural tube 
malformations or the change was a mere consequence of neural tube 
malformations caused by the glucotoxicity of maternal diabetes. 
 
3. Expression of genes that are involved in glucose metabolism and that 
respond to hypoxia is altered in cranial neural tubes of embryos from 
diabetic mice  
Abnormal metabolic environment caused by maternal diabetes appears to 
contribute to neural tube malformations in mouse embryos. Several studies have 
shown that a deficiency of myoinositol, abnormalities of arachidonic acid and 
prostaglandin metabolism, excessive production of ROS, activation of 
diacylglycerol-protein kinase C and induced-hypoxic as well as oxidative stress 
mediate the toxic effect of maternal diabetes on development of various organs 
including the neural tube (Baker et al., 1990; Chang et al., 2003; Goldman et al., 
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1985; Hashimoto et al., 1990; Hiramatsu et al., 2002; Li et al., 2005). The present 
study further revealed an altered expression of genes involving hypoxia and 
glycolysis in cranial neural tubes of embryos from diabetic pregnancy. 
Physiologically optimal oxygenation in all cells is essential to the survival of 
embryos (Michiels, 2004). Limitation of oxygen availability to the cells and 
tissues contributes to the several pathological conditions. However, the cells are 
capable of triggering an adaptive response to hypoxic condition by increasing the 
efficiency of energy producing pathways, mainly through increased anaerobic 
glycolysis activity, and on the other hand by decreasing energy-consuming 
processes (Boutilier, 2001). Recently it has been shown that maternal diabetes 
induces excessive physiological hypoxia in embryos and many of the maternal 
diabetes-induced changes in various tissues during development are the results of 
hypoxia-induced oxidative stress (Li et al., 2005). In the present study, the maternal 
diabetes-induced physiological hypoxia appeared to have triggered an adaptive 
response in the cranial neural tube by activating the expression of several genes 
encoding enzymes involved in aerobic and anaerobic glycolysis pathways (such as 
phosphoglycerate kinase 1, pyruvate kinase, phosphofructokinases, aldolase 1A, 
enolase 1, 2, 3, lactate dehydrogenase and hexokinases) that help to increase the 
energy production by decreasing hypoxic state in the neural tissue of embryos from 
diabetic mice.  
However, the adaptive response seems to be insufficient to reverse the 
hypoxic state of the neural tissue in embryos from diabetic mice as there is a 
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continuously increased glucose transport from maternal circulation and increased 
oxygen consumption which subsequently leads to depletion of oxygen availability 
in the neural tissue. Hence, it is suggested that contribution of hypoxia-induced 
oxidative stress to the cranial neural tube malformations in embryos of diabetic 
mice can not be excluded. 
Further, the transcriptional response to excessive hypoxia is mediated largely 
by the action of hypoxia-inducible factor-1α (HIF-1α) which is upregulated under 
hypoxia and rapidly degraded in the presence of oxygen (Wang et al., 1995). 
HIF-1α which has been implicated in a range of brain pathologies can be harmful 
or beneficial, depending on the circumstances (Bergeron et al., 1999; Gidday et al., 
1999). In the present study, the upregulation of Hif-1α expression appears to be 
harmful to the development of cranial neural tubes in embryos of diabetic 
pregnancy as it has been shown to mediate the hypoxia-induced apoptosis by 
promoting the transcription of  Bnip3, a pro-apoptotic member of the Bcl family 
of cell death factors and to contribute to the cell growth arrest by upregulating the 
expression of cyclin-dependent kinase inhibitor 1A (P21) (Bruick, 2000; Feldser 
et al., 1999; Goda et al., 2003). Taken together, the altered expression of genes 
that respond to hypoxia appears to be associated with cranial neural tube 
malformations in embryos from diabetic mice. Further, hypoxia is an important 
factor contributing to neural tube malformations since hypoxia-induced oxidative 
stress has been shown to impair the neuronal migration and maturation (Li et al., 
2005; Zechel et al., 2005). 
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4. Development of choroid plexus is impaired in the cranial neural tubes of 
embryos from diabetic mice 
During neurodevelopment, choroid plexus (CP) develops in the 4th, lateral and 
3rd ventricles of the cranial neural tube and functions as the dorsal signaling 
centre (Dziegielewska et al., 2001; Yamamoto et al., 1996). The CP epithelial 
cells produce cerebrospinal fluid (CSF) which provides an essential expanding 
mechanism that determines the shape of the brain. CSF also transfers nutrients, 
proteins and other molecules required for neuroepithelial cell survival as well as 
proliferation and neurogenesis during brain development (Gato et al., 2005; Miyan 
et al., 2003; Parada et al., 2005). In the present study, the development of CP and 
its epithelial cells was found to be impaired in embryos (E11.5-13.5) of diabetic 
pregnancy. In addition, the number of proliferating cells in the adjacent 
ventricular zone that contains ependymal cells which are considered to be the 
origin of CP epithelial cells (Matsumoto et al., 2003) and in the base of the CP, 
was significantly decreased in embryos of diabetic pregnancy, indicating that the 
impaired development of CP is associated with reduced proliferation of CP 
epithelial progenitor cells caused by maternal diabetes. Further, the malformation 
of CP observed in embryos of diabetic mice appears to be partly contributed by 
the downregulation of insulin-like growth factor 2 (Igf-2), a polypeptide hormone 
which functions as a mitogen during embryogenesis (Eicher et al., 1993; Lee et al., 
1990) and as a morphogen in inducing differentiation of CP epithelial cells during 
brain development (Cavallaro et al., 1993). The abnormal development of CP also 
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indicates the decrease in CSF production, which may be associated with impaired 
proliferation of neuroepithelial cells, neurogenesis and subsequently cranial neural 
tube dysmorphogenesis in embryos of diabetic mice.  
CP epithelial cells have been shown to synthesize and release several 
macromolecules into the CSF. Transthyretin (Ttr) which is involved in the 
transport of thyroxine and retinol (a metabolite of vitamin A) from the peripheral 
circulation to the brain (Dickson et al., 1987; Ferguson et al., 1975; Raz et al., 
1970), is the major protein synthesized by the CP epithelial cells. Thyroxine and 
retinol regulate neuronal differentiation in the developing brain (Kilby, 2003; 
Maden, 2002). Moreover, congenital hypothyroidism (causing thyroid hormone 
deficiency in the circulation) leads to devastating effects upon brain development 
resulting in cognitive deficits in infants (Oerbeck et al., 2007; Santalucia et al., 
2006). Maternal diabetes has also been shown to affect the level of fetal brain 
thyroxine, T3 and T4 (Calvo et al., 1997) and subsequently intellectual 
development and behavior of the brain in infants (Rizzo et al., 1991). Taken 
together, in the present study, a significant reduction of mRNA and protein 
expression of Ttr in cranial neural tubes of E11.5-E13.5 embryos from diabetic 
pregnancy could reduce the availability of thyroxine and retinol in the neural 
tissue, thereby resulting in abnormal brain development which may subsequently 
contribute to intellectual impairment of the offspring as reported in human (Rizzo 
et al., 1991). 
In conclusion, maternal diabetes induces metabolic derangements in the 
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cranial neural tube by altering the expression of genes involved in cellular 
metabolism such as glycolysis and in physiological hypoxia. The metabolic 
changes are associated with altered expression of genes involved in apoptosis, 
proliferation, migration and differentiation of neurons. Moreover, malformation of 
the CP and the ventricular systems together with reduced production of Ttr, Igf-2 
and other components of CSF appear to influence the neuroepithelial survival, 
proliferation and neurogenesis. It is possible that these changes may impede 
further development of functional domains of the brain (including the 
telencephalon derivatives, i.e., cerebral cortex; diencephalon derivatives, i.e., 
hypothalamus; and rhombencephalon derivatives, i.e., pons, medulla oblongata, 
etc.) and subsequently contribute to intellectual impairment in the offspring of 
diabetic mothers. However, an extensive follow-up study is required to understand 
the molecular mechanisms and consequence of cranial neural tube malformations 
observed in embryos of diabetic mice. 
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A high frequency of birth defects has been widely reported in infants born to 
diabetic mothers (Hanson et al., 1990; Mills, 1982). Experimental analysis in 
animal models also revealed that there is an increased risk for fetal malformations 
and spontaneous abortions in diabetic pregnancy (Chang et al., 2003; Sakamaki et 
al., 1999). Although most neonatal problems have declined, diabetes-associated 
anomalies remain a major health problem having significant social and financial 
implications. Gestational diabetes develops in 2-12% of total pregnancies, 
depending on ethnic background. In Asia, it accounts for 4-6% of total 
pregnancies. About 15% of the fetuses from diabetic pregnancy display congenital 
malformations in various organ systems including the nervous system (Eriksson, 
1995; Kucera, 1971). The association between maternal diabetes and the incidence 
of congenital malformations including neural tube defects has been well 
established. The basis of these malformations is quite variable and may include 
chromosomal aberrations, mutation of genes, environmental factors, interactions 
between hereditary tendencies and genetic factors, and idiopathic causes (Kalter 
and Warkany, 1983). 
High blood sugar levels in the fetus at the time of conception and in the first 
few weeks of development are associated with higher rates of congenital anomalies 
(Temple et al., 2002). Despite apparent declines in pregnancy-related complications 
among women with diabetes mellitus, recent studies continue to show increased 
rates of perinatal mortality and congenital anomalies in these women compared to 
the non-diabetes mellitus population (Casson et al., 1997; Cundy et al., 2000; 
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Hawthorne et al., 1997; Towner et al., 1995). It has been shown that congenital 
anomalies can be almost completely avoided with careful blood sugar control prior 
to conception and during organ development in the first few weeks of pregnancy 
(Fuhrmann et al., 1984; Kitzmiller et al., 1991; Steel et al., 1990). Moreover, the 
frequency of embryonic malformations in diabetic pregnancy has been reported to 
be markedly decreased by dietary supplements of anti-oxidants, such as vitamin C 
or E and butylated hydroxytoluene (Chang et al., 2003; Eriksson and Borg, 1991; 
Eriksson and Siman, 1996; Siman and Eriksson, 1997), indicating that oxidative 
stress is involved in the etiology of embryonic dysmorphogenesis. 
In recent years, considerable efforts have been made to investigate the etiology 
of birth defects among infants of diabetic mothers. It has been shown that 
diabetes-induced embryonic dysmorphogenesis is accompanied by some metabolic 
abnormalities including elevated superoxide dismutase activity, reduced levels of 
myoinositol and arachidonic acid, and inhibition of the pentose phosphate shunt 
pathway (Cederberg et al., 2000; Eriksson, 1991; Eriksson and Borg, 1993; 
Goldman et al., 1985; Hashimoto et al., 1990). Further, several experimental studies 
have shown that neural tube anomalies in embryos of diabetic mice are associated 
with altered expression of genes involved in the neural tube development (Chang et 
al., 2003; Li et al., 2005; Liao et al., 2004; Loeken, 2005; Loeken, 2006). More 
recently, it has been shown that high-glucose concentrations alter the expression of 
genes that are involved in proliferation and differentiation of neural stem cells 
(NSCs), indicating the basis for the CNS malformations in infants of diabetic 
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mothers (Fu et al., 2006). The present study is the first of its kind demonstrating the 
differential gene expression profiling of cranial neural tubes in embryos of diabetic 
mice in comparison to that of embryos from control mice. 
The data presented in this thesis clearly demonstrate that maternal diabetes 
induces metabolic derangements in the cranial neural tube by altering the 
expression of genes involved in cellular metabolism such as glycolysis and in 
physiological hypoxia. The metabolic changes are associated with altered 
expression of genes involved in apoptosis, proliferation, migration and 
differentiation of neuronal cell types. Moreover, malformation of the CP and the 
ventricular systems together with reduced production of Ttr, Igf-2 and other 
components of the CSF appear to influence the neuroepithelial survival, 
proliferation and neurogenesis. It is possible that these changes may impede 
further development of functional domains of the brain and subsequently 
contribute to intellectual impairment in the offspring of diabetic mothers. 
However, an extensive follow-up study is required to understand the molecular 
mechanisms and consequence of cranial neural tube malformations observed in 
embryos of diabetic mice. 
The predisposing effect of intrauterine exposure to a diabetic environment 
has major public health implications in the present context of the growing diabetes 
epidemic. Since the mechanisms of fetal malformations in diabetic pregnancies 
appear to be complex, it is suggested that intensive glycemic control in the 
preconception period and throughout pregnancy may contribute to a decrease in 
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the prevalence of diabetes-induced malformations in the fetus. Based on present 
findings together with previous reports, it is also suggested that supplementation of 
molecules that are found to be deficient in embryos under hyperglycemic conditions 
and antioxidants to alleviate the adverse effects of oxidative stress would prevent 
embryonic malformations.  
Although the present study does not reveal the molecular mechanisms that 
contribute to the neural tube anomalies, it provides a clue for changes in molecular 
cues that guide the development of different functional regions of the brain. This 
direction of study is of clinical importance as it could open up new vistas of 
research to develop safer modes of therapeutic strategies and multi-nutrient dietary 
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Fig.1. Embryos (E11.5) obtained from control (A) and diabetic (B) mice. The 
embryo from a diabetic mouse exhibits exencephaly phenotype extending from 
the telencephalon to rhombencephalon (arrows). The line in Fig A and B shows 
the approximate region of cranial neural tube (containing forebrain, midbrain and 
hindbrain) that was used for RNA extraction in this study. tc, telencephalon; dc, 
diencephalon; rc, rhombencephalon; e, eye; ov, otic vesicle. Scale bar: 1mm 
 
 





























Fig.2. Transverse sections (stained with Hematoxylin & Eosin) showing 
morphological changes in the telencephalon, diencephalon and rhombencephalon 
of embryos (E11.5) obtained from control (A, C) and diabetic (B, D) mice. The 
neuroepithelia of forebrain including telencephalon and diencephalon and the 
rhombencephalon in embryos of diabetic mice appear to be distorted and fused. 
The size and volume of the 3rd and 4th ventricles (III and IV) are markedly reduced 
in cranial neural tubes of embryos from diabetic mice in comparison to that of 
embryos from normal mice. LV, lateral ventricle; III, third ventricle; IV, fourth 
ventricle; tel, telencephalon; dc, diencephalon; rb, rhombencephalon. Scale bar: 
200 µm. 






























Fig.3. Cluster analysis showing changes in gene expression profiles of the cranial 
neural tube in embryos from diabetic mice. The data analysis revealed the 
differential expression of 1613 genes between embryos of control and diabetic 
mice. Agglomerative average-linkage hierarchical clustering of the six 
independent samples was obtained for selected groups of genes using GeneSpring 
7.3 software. Each colored box represents the normalized expression level of a 
given gene in each sample and is colored according to the fold change.  
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Fig.4. Functional categorization of genes that are differentially expressed in 
cranial neural tubes of embryos (E11.5) from diabetic mice in comparison to that 
of control mice. About 390 genes displaying greater than 2-fold changes in 
expression level are grouped into 9 categories as follow: (1) metabolism (27.7%); 
(2) cellular physiological process (20.3%); (3) cell communication (12.1%); (4) 
morphogenesis (6.9%); (5) response to stimulus (3.8%); (6) cell death (2.3%); (7) 
cell differentiation (2.1%); (8) small subsets of genes (5.4%) that are implicated in 
regulation of cellular process, regulation of gene expression, epigenetic, 
extracellular structure organization, biogenesis and cell adhesion; and (9) 
“unclassified” genes with no functional annotation. 
 

























Fig.5. Microarray analysis shows that expression of genes that encode key enzymes 
involved in glycolysis pathway is upregulated in cranial neural tubes of embryos 
from diabetic mice. In the flow chart of glycolysis pathway, substrates and products 
are in rectangle, enzymes are in circle, genes are in italic format and fold changes of 
gene expression are in parenthesis.  Abbreviations used: 1,3-BPG, 
1,3-bisphosphoglycerate; 2-PGA, 2-phosphoglycerate; 3-PGA, 3-phosphoglycerate; 
ALD, aldolase; ENO, enolase; F-1,6-BP, fructose 1,6-bisphosphate; F-6-P, fructose 
6-phosphate; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; G-6-P, glucose 
6-phosphate; GPI, glucose phosphate isomerase; GADP, glyceraldehyde 
3-phosphate; DHAP, dihydroxyacetone phosphate; HK, hexokinase; LAC, lactate; 
LDH, lactate dehydrogenase; PEP, phosphoenolpyruvate; PFK, 
phosphofructokinase; PGK, phosphoglycerate kinase; PGM, phosphoglycerate 
mutase; PK, pyruvate kinase; PYR, pyruvate; TPI, triosephosphate isomerase; aldoa, 
aldolase A; pkm2, pyruvate kinase, muscle; pfkl, phosphofructokinase, liver; pfkp, 
phosphofructokinase, platelet 
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Fig.6. The real time RT-PCR analysis of mRNA expression of some genes which 
are involved in glycolysis in cranial neural tubes of embryos (E11.5) from control 
and diabetic mice. The mRNA expression levels (E) hk1, hk2, pfkl, pfkp pkm2, and 
ldh are increased in cranial neural tubes of embryos from diabetic mice compared 
with that of embryos from control mice. Panels A and C show the size of PCR 
products loaded on agarose gels. Panels B and D show the melting curves which 
depict the specificity of the PCR products amplified. The data are presented as 
mean ± SE (n=4), *p<0.05. 
 
 













































































Fig.7. Hif-1α gene (127bp) product (A) is amplified in the cranial neural tube of 
E11.5 mouse embryos. Melting curve (B) indicates the specificity of the product. 
The quantitative real time RT-PCR analysis (C) shows that expression level of 
Hif-1α is significantly increased in the cranial neural tubes of embryos derived 
from diabetic mice in comparison to that of embryos from control mice (mean ± 
S.E, n=4, *p<0.05). 
























Fig.8. Western blot analysis (A) shows the expression of Hif1α protein (120kDa) 
and ß-actin (42kDa) in the cranial neural tubes of E11.5 embryos from control and 
diabetic mice. The quantity of Hif1 protein (B) is found to be significantly 
increased in cranial neural tubes of embryos from diabetic mice compared to that 
of embryos from control mice (mean ± S.E, n = 3, *p < 0.05) 
























Hif1α protein expression by western blot 
Figure 8







Fig.9. Vegf gene (138bp) product (A) is amplified in the cranial neural tube of 
E11.5 mouse embryos. Melting curve (B) indicates the specificity of the product. 
The quantitative real time RT-PCR (C) shows that expression level of Vegf is 
significantly increased in cranial neural tubes of embryos derived from diabetic 
mice in comparison to that of embryos from control mice (mean ± SE, n=4, 
**p<0.01). 
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Fig.10. Western blot (A) shows the protein expression of Vegf (20kDa) and 
ß-actin (42kDa) in cranial neural tubes of E11.5 embryos from control and 
diabetic mice. The Vegf protein expression level (B) is found to be significantly 
increased in cranial neural tubes of embryos from diabetic mice compared to that 
of embryos from control mice (mean ± SE, n = 3, *p < 0.05) 
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Fig.11. Apoptosis is induced in cranial neural tubes of embryos (E11.5) from 
diabetic mice as revealed by TUNEL assay. Apoptotic cells (arrows in B, D, and F) 
are markedly increased in the neuroepithelia of telencephalon (B), diencephalons 
(D) and rhombencephalon (F). However, apoptotic cells are hardly detectable in 
neuroepithela (A, C, E) of embryos from control mice. tc, telencephalon; dc, 
diencephalon; rc, rhombencephalon. Scale bar: 50 µm 


















Fig.12. Transverse sections showing BrdU-labelled cells (red) in cranial neural 
tubes of embryos (E11.5) from control and diabetic mice. Sections are 
counterstained with DAPI (blue), a nuclear marker. The BrdU-labelled cells are 
evenly distributed (arrows) in the entire forebrain (A) and rhombencephalon (C) 
of control embryos. In embryos of diabetic mice, the proliferating cells (arrows) 
appear to be decreased in neuroepithelia of the forebrain (B) and 
rhombencephalon (D). Quantitative analysis (E) shows that the percentage of 
BrdU-labelled cells in the neuroepithelia of telencephalon, diencephalon and 
rhombencephalon was significantly decreased in embryos from diabetic mice 
compared with that of embryos from control mice. tc, telencephalon; dc, 
diencephalon; rc, rhombencephalon; LV, lateral ventricle; III, third ventricle; IV, 
fourth ventricle. Scale bar (A-D): 200 µm. Data are presented as mean values of 
% of BrdU positive cells ± S.E (n=3). *p<0.05; **p<0.01. 
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Fig.13. Pax6 gene (144bp) product is amplified by the real time RT-PCR (A). 
Melting curve (B) indicates the specificity of the product. The quantitative real 
time RT-PCR analysis (C) shows that expression level of Pax6 is significantly 
decreased in the cranial neural tube of E11.5 embryos from diabetic mice in 
comparison to that of embryos from control mice. The data are presented as mean 

















Pax 6 mRNA expression 






Fig.14. In situ hybridization analysis of pax 6 mRNA expression in cranial neural 
tubes of embryos (E11.5) from control and diabetic mice. Expression of pax 6 in 
embryos of control mice (A-C) is localized to the telencephalon and diencephalon 
(arrow-heads). No expression is detectable in rhombencephalon. In embryos of 
diabetic mice, the expression level of pax 6 (D-F) is markedly reduced and the 
domain is distorted. Arrows in D show the cranial neural tube closure defects in 
embryos of diabetic mice. Red lines depict the approximate planes of transverse 
sections. Letters on the line indicate the locations of the sections shown in B, C, 
E,and F. tc, telencephalon; dc, diencephalon; rc, rhombencephalon. Scale bar: 
1mm (A, D); 200 µm (B,C,E,F). 








































Fig.15. Ngn2 gene (124bp) product (A) is amplified by the real time RT-PCR. 
Melting curve (B) indicates the specificity of the product. The quantitative real 
time RT-PCR (C) shows that expression level of Ngn2 is significantly decreased 
in the cranial neural tube of E11.5 embryos derived from diabetic mice in 
comparison to that of embryos from control mice. The data are presented as mean 
± S.E (n=4), *p<0.05. 
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Fig.16. In situ hybridization analysis of Ngn2 mRNA expression in cranial neural 
tubes of embryos (E11.5) from control and diabetic mice. Expression domain of 
Ngn2 is restricted to the telencephalon, diencephalon and rhombencephalon 
(arrow-heads) in embryos of control mice (A-D). However, its expression domain 
is disrupted and the expression level appears to be decreased in the telencephalon 
and diencephalon of embryos from diabetic mice (E-G). However, the expression 
level of Ngn2 appears to be unchanged in the rhombencephalon of embryos from 
diabetic mice (H) compared with the control (D). Arrows in panel E show the 
cranial neural tube closure defect in embryos of diabetic mice. Red lines in panels 
A & E indicate the approximate planes of transverse sections. Letters on the lines 
depict the locations of sections shown in B-D and F-H. tc, telencephalon; dc, 
diencephalon; rc, rhombencephalon. Scale bar: 1mm (A, E); 200 µm (B-D, F-H). 
 


































































Fig.17. Immunofluorescence staining of Dcx (green) and Blbp (red) in transverse 
sections through telencephalon, diencephalon and rhombencephalon of embryos 
(E11.5) from control (A, C, E) and diabetic (B, D, F) mice. Sections are 
counterstained with DAPI (blue). The number of Dcx positive cells (arrows) in the 
telencephalon, diencephalon and rhombencephalon of embryos from diabetic mice 
(B, D) appears to be decreased, compared to that of controls (A, C). In addition, a 
decreased number of Blbp-positive cells (arrow-heads) is clearly seen in the 
telencephalon, diencephalon and rhombencephalon of embryos from diabetic mice 
(B, D) in comparison with that of embryos from control mice (A, C). 
Blbp-positive radial glial cells (arrow-heads) exhibit elongated processes (arrows) 
which extend to the pial surface (E). However, processes of these cells (arrows) 
appear to be disrupted in the neuroepithelia of embryos from diabetic mice (F). 
Panels E & F are magnified regions of boxes shown in panels C & D, respectively. 
tc, telencephalon; dc, diencephalon; rc, rhombencephalon. Scale bar: 200µm 
(A-D); 50µm (E, F) 
 
































Fig.18. Transverse sections (stained with Hematoxylin & Eosin) display 
developing choroid plexus (CP) in the 4th ventricle (IV) of cranial neural tubes in 
embryos (E13.5) of control (A, C, E) and diabetic (B, D, F) mice. The 
development of CP in embryos of diabetic mice appears to be markedly impaired. 
In addition, the volume of the 4th ventricle is greatly reduced in the embryo of 
diabetic mice. Panels E and F are enlarged regions that are outlined in panels C & 
D, respectively. Scale bar: (A-B): 400µm; (C-D): 200µm: (E-F): 25µm




























Fig.19. Quantitative analysis reveals that the number of epithelial cells in the 
choroid plexus is significantly decreased in embryos of diabetic mice compared 
with that of embryos from control mice. The data are presented as mean ± S.E 
(n=3), *p<0.05. 



































Fig.20. Ttr gene product (112bp) is amplified in cranial neural tubes of mouse 
embryos by the real time RT-PCR (A). Melting curve indicates the specificity of 
the product (B). The quantitative real time RT-PCR (C) shows that expression 
level of Ttr is significantly decreased in cranial neural tubes of E11.5 and E13.5 
embryos derived from diabetic mice in comparison to that of embryos from 
control mice. The data are presented as mean ± S.E (n=4), *p<0.05. 
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Fig.21. Immunostaining of Ttr protein is detected in the tela choroidea (arrow in 
A) and choroid plexus epithelium (arrows in C) in cranial neural tubes of E11.5 
and E13.5 embryos respectively. The staining appears to be markedly reduced in 
the tela choroidea (arrow in B) of embryos (E11.5) from diabetic mice and the 
choroid plexus epithelium (arrows in D) of embryos (E13.5) from diabetic mice 
compared with that of embryos from control mice (A and C). CP, choroid plexus; 
IV, fourth ventricle; LV, lateral ventricle; TC, tela choroidea. Scale bar: 50µm 
 
























Fig.22. Igf-2 gene product (138bp) is amplified in cranial neural tubes of mouse 
embryos by the real time RT-PCR (A). Melting curve indicates the specificity of 
the product (B). The quantitative real time RT-PCR (C) shows that expression 
level of Igf-2 is significantly decreased in cranial neural tubes of E11.5 and E13.5 
embryos derived from diabetic mice in comparison to that of embryos from 
control mice. The data are presented as mean ± S.E (n=4), *p<0.05. 
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Fig.23. Immunostaining of Igf-2 protein is detected in the tela choroidea (arrow in 
A) and choroid plexus epithelium (arrows in C) in cranial neural tubes of E11.5 
and E13.5 embryos, respectively. The immunostaining of Igf-2 is hardly 
detectable in the tela choroidea of E11.5 embryos from diabetic mice (B) and 
appears to be markedly reduced in the choroid plexus epithelium (arrows in D) of 
E13.5 embryos from diabetic mice (D) compared with that of embryos from 
control mice (A, C). CP, choroid plexus; IV, fourth ventricle; LV, lateral ventricle; 
TC, tela choroidea. Scale bar: (A-D): 50µm 
 


























Fig.24. Cell proliferation index by BrdU incorporation in the base of the choroid 
plexus (CP) and adjacent neuroepithelia around the 4th ventricle (IV) in embryos 
(E13.5) from control and diabetic mice (A-E). Immunostaining shows that the 
number of BrdU labeled cells (arrows) is markedly decreased in the base of the 
CP and adjacent neuroepithelia in embryos from diabetic mice (B, D) compared 
with that of embryos from control mice (A, C). Panels C and D are enlarged 
portions that are outlined in panels A & B, respectively. Quantitative analysis (E) 
reveals that the percentage of BrdU-labeled cells is significantly decreased in the 
base of the CP and adjacent neuroepithelia in embryos of diabetic mice compared 
with that of embryos from control mice.  The data are presented as mean values 
of % of BrdU labeled cells ± S.E (n=3), **p<0.01. Scale bar: (A, B): 50um; (C, 
D): 20um. 















































TABLES              
Table 5: Microarray results showing altered expression of genes in cranial neural 
tubes of embryos from diabetic mice are validated by the real time RT-PCR 
 
Fold Changes 




NM_013697 transthyretin -5.9 -6.8 
NM_010514 insulin-like growth factor 2 -1.8 -3.7 
NM_010025 doublecortin -1.9 -1.8 
NM_007523 BCL2-antagonist/killer 1 1.7 1.4 
NM_011249 retinoblastoma-like 1 3.6 1.6 
NM_009760 
BCL2/adenovirus E1B 19kDa-interacting protein 
1, NIP3 
4.5 1.4 
NM_016669 crystallin, mu 2.1 2.2 









TABLES              
Table 6: Changes in expression of genes that are involved in glycolysis and that 
respond to hypoxia 
 
Accession 
No. Gene Name 
Fold 
Change Gene Function 
NM_007438 aldolase 1, A isoform # 2.1 Response to hypoxia, glycolysis 
and glucose metabolism 
NM_023119 enolase 1, alpha non-neuron # 1.4 Response to hypoxia, glycolysis 
and glucose metabolism 
NM_013509 enolase 2, gamma neuronal 3.9 Glycolysis and glucose 
metabolism 
NM_007933 enolase 3, beta muscle 1.6 Glycolysis and glucose 
metabolism 
NM_008155 glucose phosphate isomerase 1 2.0 Glycolysis and glucose 
metabolism 
NM_010438 hexokinase 1 # 1.5 Response to hypoxia, glycolysis 
and glucose metabolism 
NM_013820 hexokinase 2 # 2.8 Response to hypoxia, glycolysis 
and glucose metabolism 
NM_010699 lactate dehydrogenase 1, A chain # 1.5 Response to hypoxia, glycolysis 
and glucose metabolism 
NM_008826 phosphofructokinase, liver, B-type # 1.8 Response to hypoxia, glycolysis 
and glucose metabolism 
NM_019703 phosphofructokinase, platelet 1.6 Response to hypoxia, glycolysis 
and glucose metabolism 
NM_008828 phosphoglycerate kinase 1 # 1.6 Response to hypoxia, glycolysis 
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NM_023418 phosphoglycerate mutase 1 1.7 Glycolysis and glucose 
metabolism 
NM_011099 pyruvate kinase, muscle # 1.4 Response to hypoxia, glycolysis 
and glucose metabolism 
NM_009415 triosephosphate isomerase 1 # 1.6 Response to hypoxia, glycolysis 
and glucose metabolism 
NM_009760 BCL2/adenovirus E1B 
19kDa-interacting protein 1, NIP3 # 
4.5 Response to hypoxia and apoptosis
NM_008343 Igf binding protein 3 # 1.5 Response to hypoxia, cell 
proliferation and apoptosis 
NM_010431 hypoxia inducible factor 1, alpha 
subunit 
1.5 Response to hypoxia, positive 
regulation of vascular endothelial 




vascular endothelial growth factor A 
# 
2.1 Response to hypoxia, cell 
proliferation and angiogenesis 
NM_011400 solute carrier family 2 (facilitated 
glucose transporter), member 1 
2.9 Response to hypoxia and glucose 
transport 
NM_030696 solute carrier family 16 
(monocarboxylic acid transporters), 
member 3 
3.5 Response to hypoxia and 
monocarboxylic acid transport 
NM_007669 cyclin-dependent kinase inhibitor 
1A (P21) # 
1.7 Response to hypoxia and negative 
regulation of cell proliferation 
NM_011030 procollagen proline, 2-oxoglutarate 
4-dioxygenase (proline 
4-hydroxylase) alpha 1 polypeptide 
# 
2.9 Response to hypoxia and protein 
metabolism 
NM_011498 basic helix-loop-helix domain 
containing, class B2 
4.9 Response to hypoxia and 
regulation of transcription 
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Table 7: Changes in expression of genes that are involved in apoptosis 
 
Accession 
No. Gene Name 
Fold 
Change Gene Function 
NM_009760 BCL2/adenovirus E1B 19kDa 
interacting protein 1, NIP3 
4.5 apoptosis 
NM_009761 BCL2/adenovirus E1B 19kDa 
interacting protein 3-like 
1.5 apoptosis 
NM_007523 BCL2-antagonist/killer 1 1.7 apoptosis and caspase activation 
via cytochrome c 
NM_007544 BH3 interacting domain death 
agonist 
1.6 apoptosis 
NM_028133 EGL nine homolog 3 2.8 apoptosis and protein metabolism 
NM_010370 granzyme A 6.0 apoptosis and cytolysis 
NM_008655 growth arrest and DNA damage 
inducible 45 beta 
1.9 apoptosis and activation of 
MAPKK 
NM_030152 nucleolar protein 3 (apoptosis 
repressor with CARD domain) 
-1.5 apoptosis and nuclear mRNA 
splicing, via spliceosome 
NM_009383 Tial1 cytotoxic granule-associated 
RNA binding protein-like 1 
1.8 apoptosis 
NM_011640 transformation related protein 53 2.3 apoptosis and DNA damage 
response, signal transduction by 
p53 class mediator 
NM_010177 tumor necrosis factor (ligand) 
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Table 8: Changes in expression of genes that regulate cell proliferation, 
differentiation, migration and neurogenesis during brain development 
Accession 
No. Gene Name 
Fold 
Change Gene Function 
NM_009655 activated leukocyte cell adhesion 
molecule 
-2.2 cell adhesion 
NM_010875 neural cell adhesion molecule 1 -2.1 cell adhesion 
NM_130448 protocadherin 18 -1.6 cell adhesion 
NM_008714 Notch gene homolog 1 -1.6 cell differentiation 
NM_008716 Notch gene homolog 3 1.6 cell differentiation 
NM_008782 paired box gene 5 2.3 cell differentiation 
NM_021881 quaking -1.8 cell differentiation 
NM_008927 mitogen activated protein kinase 
kinase 1 
1.5 cell differentiation and map kinase 
pathway 
NM_009170 sonic hedgehog 1.5 brain morphogenesis  
NM_007554 bone morphogenetic protein 4 -1.5 cell fate commitment 
NM_021272 brain lipid binding protein -1.8 cell migration 
NM_009409 topoisomerase (DNA) II beta -1.6 cell migration and forebrain 
development 
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NM_010514 insulin-like growth factor 2 -1.8 cell proliferation 
NM_009367 transforming growth factor, beta 2 -2.3 cell proliferation 
NM_008634 microtubule-associated protein 1 B -2.4 dendrite morphogenesis 
NM_133719 meteorin, glial cell differentiation 
regulator 
1.5 glia cell differentiation 
NM_001033 
635 
zinc finger homeobox 1b -1.5 neural crest cell migration 
NM_019978 double cortin and 
calcium/calmodulin dependent 
protein kinase like 1 
-1.9 neurogenesis 
NM_010025 doublecortin -1.9 neurogenesis 
NM_146100 internexin neuronal intermediate 
filament protein, alpha 
-2.2 neurogenesis 
NM_010894 neurogenic differentiation 1 -1.9 neurogenesis 
NM_009718 neurogenin 2 -1.5 neurogenesis 
NM_013627 paired box gene 6 -2.1 neurogenesis 
NM_178804 slit homolog 2 -1.5 neurogenesis 
 
NM_019479 hairy and enhancer of split 6 -1.5 neurogenesis  
NM_010512 insulin-like growth factor 1 -1.8 neurogenesis, anti-apoptosis and 
glial cell differentiation  
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NM_010897 neurofibromatosis 1 1.6 regulation of glial cell 
differentiation 
NM_010133 engrailed 1 1.5 regulation of transcription 
NM_010134 engrailed 2 1.6 regulation of transcription 
NM_010835 homeo box, msh-like 1 -1.6 regulation of transcription 
NM_008687 nuclear factor I/B -1.7 regulation of transcription 
NM_009697 nuclear receptor subfamily 2, 
group F, member 2 
1.5 regulation of transcription 
NM_013634 peroxisome proliferator activated 
receptor binding protein 
-2.6 regulation of transcription 
NM_009189 sine oculis-related homeobox 1 
homolog 
-1.8 regulation of transcription 
NM_172688 mitogen activated protein kinase 
kinase kinase 7 
-1.7 transforming growth factor beta 
receptor signaling pathway 
NM_009370 transforming growth factor, beta 
receptor I 
-1.5 transforming growth factor beta 
receptor signaling pathway 
 
 
 
205 
